UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 10-Q
☒ QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the quarterly period ended June 30, 2024
or
☐ TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from __________ to __________
Commission
File No.: 000-54624
Bowmo, inc. |
(Exact name of registrant as specified in its charter) |
Wyoming | | 26-4144571 |
(State or other jurisdiction of incorporation) | | (IRS Employer Identification No.) |
99 Wall Street, Suite 891, New York City, New York 10005 |
(Address of principal executive offices) |
|
(212) 398-0002 |
(Registrant’s telephone number, including area code) |
Former
name, former address and former fiscal year, if changed since last report
Indicate
by check mark whether the registrant (1) has filed all reports to be filed by Section 13 and Section 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to files such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
☐ | Large accelerated filer | ☐ | Accelerated filer |
☒ | Non-accelerated filer | ☒ | Smaller reporting company |
| | ☐ | Emerging growth company |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12-b2 of the Exchange Act). Yes ☐ No ☒
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common stock | | BOMO | | OTC Markets - Other |
Indicate
the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of November
13, 2024, there were 136,458,010 shares of common stock outstanding.
Table
of Contents
PART
I – FINANCIAL INFORMATION
Item
1. Financial Statements.
Bowmo,
Inc. and Subsidiaries
Consolidated Balance Sheets
|
|
June
30, 2024
(unaudited) |
|
|
December
31, 2023
(audited) |
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
Cash
and cash equivalents |
|
$ |
12,517 |
|
|
$ |
6,308 |
|
Accounts
receivable |
|
|
18,172 |
|
|
|
18,172 |
|
Prepaid
expenses and other current assets |
|
|
- |
|
|
|
1,838 |
|
Total
Current Assets |
|
|
30,689 |
|
|
|
26,318 |
|
|
|
|
|
|
|
|
|
|
Loan
to related party – Michael Laskshin |
|
|
24,475 |
|
|
|
- |
|
Loan
to related party – Eddie A. |
|
|
1,400 |
|
|
|
- |
|
Prepaid
expenses |
|
|
858 |
|
|
|
- |
|
Total
Other Assets |
|
|
26,733 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Total
Assets |
|
$ |
57,422 |
|
|
$ |
26,318 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS’ DEFICIT |
|
|
|
|
|
|
|
|
Current
Liabilities: |
|
|
|
|
|
|
|
|
Accounts
payable |
|
|
1,204,990 |
|
|
|
1,144,735 |
|
Accrued
expenses |
|
|
13,500 |
|
|
|
213,707 |
|
Accrued
interest |
|
|
364,598 |
|
|
|
364,598 |
|
Accrued
officer compensation |
|
|
1,533,583 |
|
|
|
1,384,499 |
|
Accrued
payroll taxes |
|
|
91,127 |
|
|
|
- |
|
Loans
payable, current portion |
|
|
30,000 |
|
|
|
30,000 |
|
Loans
payable, related party |
|
|
269,500 |
|
|
|
254,500 |
|
Convertible
Notes, net of debt discount of $273,330 and $206,570 |
|
|
105,753 |
|
|
|
440,109 |
|
Put
premium on stock settled debt |
|
|
205,684 |
|
|
|
205,684 |
|
Acquisition
payable |
|
|
200,000 |
|
|
|
- |
|
Derivative
liability |
|
|
578,363 |
|
|
|
433,818 |
|
Total
Current Liabilities |
|
|
4,597,098 |
|
|
|
4,471,650 |
|
|
|
|
|
|
|
|
|
|
Loans
payable, net of current portion |
|
|
193,202 |
|
|
|
193,202 |
|
Total
Liabilities |
|
|
4,790,300 |
|
|
|
4,664,852 |
|
|
|
|
|
|
|
|
|
|
Commitments
and Contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS’
DEFICIT: |
|
|
|
|
|
|
|
|
Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 and 0 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. |
|
|
33,815 |
|
|
|
33,815 |
|
Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 and 0 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. |
|
|
50 |
|
|
|
50 |
|
Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 and 0 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. |
|
|
50,000 |
|
|
|
50,000 |
|
Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 and 0 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. |
|
|
12 |
|
|
|
12 |
|
Series
E Preferred stock to be issued |
|
|
166,331 |
|
|
|
166,331 |
|
Series F Preferred stock, 101 shares authorized, par value $0.0001; 101 and 0 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. |
|
|
- |
|
|
|
- |
|
Series G Preferred stock, 1,000,000 shares authorized, par value $0.0001; 1,000,000 and 0 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. |
|
|
1,000 |
|
|
|
1,000 |
|
Series H Preferred stock, 1,000,000 shares authorized, par value $0.0001; 1,000,000 and 0 and 10 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. |
|
|
- |
|
|
|
10 |
|
Series AA Preferred stock, 10,000,000 shares authorized, par value $0.0001; 0 and 652,259 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. |
|
|
- |
|
|
|
- |
|
Series Super Preferred stock, 10,000,000 shares authorized, par value $0.0001; 0 and 500 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. |
|
|
- |
|
|
|
- |
|
Common stock 40,000,000,000 shares authorized, $0.00001 par value; 136,458,010 and 53,520,830 shares issued and outstanding, respectively at June 30, 2024 and December 31, 2023.* |
|
|
1,365 |
|
|
|
535 |
|
Common stock to be issued, 2,550,000 and 2,550,000 shares as of June 30, 2024 and December 31, 2023, respectively |
|
|
26 |
|
|
|
26 |
|
Treasury stock, at cost 2,917 shares as of June 30, 2024 and December 31, 2023, respectively. |
|
|
(773,500 |
) |
|
|
(773,500 |
) |
Additional
paid in capital * |
|
|
9,471,985 |
|
|
|
8,876,064 |
|
Accumulated
deficit |
|
|
(13,683,963 |
) |
|
|
(12,992,877 |
) |
Total
Stockholders’ Deficit |
|
|
(4,732,878 |
) |
|
|
(4,638,534 |
) |
Total
Liabilities and Stockholders’ Deficit |
|
$ |
57,422 |
|
|
$ |
26,318 |
|
The
accompanying notes are an integral part of these consolidated financial statements
Bowmo,
Inc. and Subsidiaries
Consolidated
Statements of Operations
| |
For
the Three Months Ended
June 30, | | |
For
the Six Months Ended
June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
| | |
| | |
| | |
| |
Revenue | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | 4,476 | |
Cost of revenue | |
| - | | |
| - | | |
| - | | |
| - | |
Gross Profit | |
| - | | |
| - | | |
| - | | |
| 4,476 | |
| |
| | | |
| | | |
| | | |
| | |
Operating Expenses | |
| | | |
| | | |
| | | |
| | |
Compensation expense | |
| 125,000 | | |
| 100,805 | | |
| 250,000 | | |
| 222,119 | |
Consulting fees | |
| - | | |
| 30,000 | | |
| - | | |
| 60,000 | |
Professional fees | |
| 7,500 | | |
| 3,415 | | |
| 65,000 | | |
| 163,469 | |
General and administrative | |
| 30,357 | | |
| 30,840 | | |
| 61,606 | | |
| 107,421 | |
Total
Operating Expenses | |
| 162,857 | | |
| 165,060 | | |
| 376,606 | | |
| 553,009 | |
| |
| | | |
| | | |
| | | |
| | v |
Loss from Operations | |
| (162,857 | ) | |
| (165,060 | ) | |
| (376,606 | ) | |
| (548,533 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other Income (Expenses) | |
| | | |
| | | |
| | | |
| | |
Interest expense | |
| - | | |
| (227,905 | ) | |
| - | | |
| (497,405 | ) |
Gain on new methodology for accounting for
debt conversion features | |
| - | | |
| - | | |
| - | | |
| - | |
Initial recognition of derivative liability | |
| - | | |
| - | | |
| - | | |
| (32,429 | ) |
Change in fair value
of derivative liability | |
| 41,646 | | |
| (872,763 | ) | |
| (314,480 | ) | |
| 430,281 | |
Total other income (expenses) | |
| 41,646 | | |
| (1,100,668 | ) | |
| (314,480 | ) | |
| (99,553 | ) |
| |
| | | |
| | | |
| | | |
| | |
Loss before income taxes | |
| (121,211 | ) | |
| (1,265,728) | | |
| (691,086 | ) | |
| (648,086 | ) |
Provision for income
taxes | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| | | |
| | | |
| | | |
| | |
NET
(Loss) Income | |
| (121,211 | ) | |
| (1,265,728 | ) | |
$ | (691,086 | ) | |
$ | (648,086 | ) |
| |
| | | |
| | | |
| | | |
| | |
Net
loss per common share – basic and diluted | |
$ | (0.00 | ) | |
$ | (0.04 | ) | |
$ | (0.01 | ) | |
$ | (0.02 | ) |
Weighted average common
shares – basic and diluted * | |
| 126,232,788 | * | |
| 32,265,169 | | |
| 72,390,257 | * | |
| 30,223,359 | |
The
accompanying notes are an integral part of these consolidated financial statements
Bowmo,
Inc. and Subsidiaries
Consolidated
Statement of Changes in Stockholders’ Deficit
For the Three and Six Ended June 30, 2024 and 2023
| |
Preferred
Stock AA | | |
Super
Preferred Stock | | |
Preferred
Stock A | | |
Preferred
Stock B | | |
Preferred
Stock C | | |
Preferred
Stock D | | |
Preferred
Stock E | | |
Preferred
Stock G | | |
Preferred
Stock H | | |
Common
Stock | | |
Common
Stock to be
issued | | |
| | |
| | |
| | |
Total
Equity | |
| |
Shares | | |
Amount
($) | | |
Shares | | |
Amount
($) | | |
Shares | | |
Amount
($) | | |
Shares | | |
Amount
($) | | |
Shares | | |
Amount
($) | | |
Shares | | |
Amount
($) | | |
Shares | | |
Amount
($) | | |
Shares | | |
Amount
($) | | |
Shares | | |
Amount
($) | | |
Shares | | |
Amount
($) | | |
Shares | | |
Amount
($) | | |
Additional
Paid-in | | |
Treasury
Stock | | |
Accumulated
Deficit | | |
Equity/(Deficit)
$ | |
Balance
as of December 31, 2022 | |
| 0 | | |
$ | 0 | | |
| 0 | | |
$ | 0 | | |
| 3,381,520 | | |
$ | 33,815 | | |
| 5,000 | | |
$ | 50 | | |
| 5,000,000 | | |
$ | 50,000 | | |
| 125,000 | | |
$ | 12 | | |
| 0 | | |
$ | 166,331 | | |
| 1,000,000 | | |
$ | 1,000 | | |
| 0 | | |
$ | 0 | | |
| 27,049,736,362 | | |
$ | 270,497 | | |
| 0 | | |
$ | 26 | | |
$ | 3,599,032 | | |
$ | (773,500 | ) | |
$ | (9,243,925 | ) | |
$ | (5,896,662 | ) |
Stock-based
compensation | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
$ | 56,628 | | |
| | | |
| | | |
$ | 56,628 | |
Relative
fair value of warrants issued with convertible debt | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
$ | 24,989 | | |
| | | |
| | | |
$ | 24,989 | |
Share
issued for extinguishment of convertible debt | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 5,391,441,059 | | |
$ | 53,914 | | |
| | | |
| | | |
$ | 470,731 | | |
| | | |
| | | |
$ | 524,645 | |
Net
Loss for six months ended June 30, 2023 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (648,086 | ) | |
| (648,086 | ) |
Balance
as of June 30, 2023 | |
| 0 | | |
$ | 0 | | |
| 0 | | |
$ | 0 | | |
| 3,381,520 | | |
$ | 33,815 | | |
| 5,000 | | |
$ | 50 | | |
| 5,000,000 | | |
$ | 50,000 | | |
| 125,000 | | |
$ | 12 | | |
| 0 | | |
$ | 166,331 | | |
| 1,000,000 | | |
$ | 1,000 | | |
| 0 | | |
$ | 0 | | |
| 32,441,177,421 | | |
$ | 324,412 | | |
| 0 | | |
$ | 26 | | |
$ | 4,151,380 | | |
$ | (773,500 | ) | |
$ | (9,892,011 | ) | |
$ | (5,938,485 | ) |
Balance
as of December 31, 2023 | |
| 0 | | |
| 0 | | |
| 0 | | |
| 0 | | |
| 3,381,520 | | |
| 33,815 | | |
| 5,000 | | |
| 50 | | |
| 5,000,000 | | |
| 50,000 | | |
| 125,000 | | |
| 12 | | |
| 0 | | |
$ | 166,331 | | |
| 1,000,000 | | |
$ | 1,000 | | |
| 10,000 | | |
$ | 10 | | |
| 53,520,830 | | |
$ | 535 | | |
| 0 | | |
$ | 26 | | |
$ | 8,876,064 | | |
$ | (773,500 | ) | |
| (12,992,877 | ) | |
$ | (4,638,534 | ) |
Equity
Issuance during 2024 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
$ | (10 | ) | |
| 82,937,180 | | |
$ | 829 | | |
| | | |
| | | |
$ | 368,467 | | |
| | | |
| | | |
$ | 369,286 | |
Derivative
liability adjustments for Q2 2024 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
$ | 227,455 | | |
| | | |
| | | |
$ | 227,455 | |
Net
Loss for six months ended June 30, 2024 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (691,086 | ) | |
| (691,086 | ) |
Balance
as of June 30, 2024 | |
| 0 | | |
$ | 0 | | |
| 0 | | |
$ | 0 | | |
| 3,381,520 | | |
$ | 33,815 | | |
| 5,000 | | |
$ | 50 | | |
| 5,000,000 | | |
$ | 50,000 | | |
| 125,000 | | |
$ | 12 | | |
| 0 | | |
$ | 166,331 | | |
| 1,000,000 | | |
$ | 1,000 | | |
| 10,000 | | |
$ | 0 | | |
| 136,458,010 | | |
$ | 1,365 | | |
| 0 | | |
$ | 26 | | |
$ | 9,471,985 | | |
$ | (773,500 | ) | |
$ | (13,683,963 | ) | |
$ | (4,732,878 | ) |
The
accompanying notes are an integral part of these consolidated financial statements
Bowmo,
Inc. and Subsidiaries
Consolidated
Statements of Cash Flows
| |
June 30, | | |
June 30, | |
| |
2024 | | |
2023 | |
Cash
Flows from Operating Activities | |
| | |
| |
Net
loss | |
$ | (691,086 | ) | |
$ | 648,086 | |
Adjustments
to reconcile net loss to net cash provided by (used in) operating activities: | |
| | | |
| | |
Interest
expense incurred on put premium on stock settled debt | |
| - | | |
| 60,000 | |
Amortization
of debt discount | |
| (66,760 | ) | |
| 442,550 | |
Stock-based
compensation and shares issued for services | |
| - | | |
| 154,628 | |
Expenses
incurred on extinguishment of convertible debt and accrued interest | |
| - | | |
| 20,490 | |
Initial
derivative expense | |
| - | | |
| 32,429 | |
Change
in fair value of derivative liability | |
| 314,480 | | |
| (430,281 | ) |
Changes
in operating assets and liabilities (net of amounts acquired): | |
| | | |
| | |
Accounts
receivable | |
| - | | |
| 15,543 | |
Prepaid
expenses and other current assets | |
| 980 | | |
| - | |
Related
party loans | |
| (25,875 | ) | |
| - | |
Accounts
payable | |
| (109,688 | ) | |
| 138,483 | |
Accrued
expenses | |
| (200,207 | ) | |
| (287 | ) |
Accrued
Interest | |
| - | | |
| (8,128 | ) |
Accrued
compensation | |
| 149,083 | | |
| 133,281 | |
Accrued
payroll taxes | |
| 91,127 | | |
| | |
Acquisition
payable | |
| 200,000 | | |
| - | |
Net
Cash (Used In) Provided By Operating Activities | |
| (337,946 | ) | |
| (88,378 | ) |
| |
| | | |
| | |
Cash
Flows from Investing Activities | |
| | | |
| | |
Cash
acquired in reverse merger | |
| - | | |
| - | |
Cash
acquired in acquisition | |
| - | | |
| - | |
Net
Cash Provided by Investing Activities | |
| - | | |
| - | |
| |
| | | |
| | |
Cash
Flows from Financing Activities | |
| | | |
| | |
Proceeds
from loans payable | |
| 15,000 | | |
| (980 | ) |
Proceeds
from equity issuances | |
| 596,751 | | |
| - | |
Repayment
of loans | |
| (267,596 | ) | |
| - | |
Net
Cash Provided by Financing Activities | |
| 344,155 | | |
| (980 | ) |
| |
| | | |
| | |
Net
Change in Cash and Cash Equivalents | |
| 6,209 | | |
| (89,358 | ) |
| |
| | | |
| | |
Cash
And Cash Equivalents - Beginning of Year | |
| 6,308 | | |
| 167,103 | |
| |
| | | |
| | |
Cash
And Cash Equivalents - End of Year | |
| 12,517 | | |
$ | 77,745 | |
| |
| | | |
| | |
Supplemental
Disclosure of Cash and Non-cash Transactions: | |
| | | |
| | |
Cash
paid for interest | |
$ | - | | |
$ | - | |
Cash
paid for interest | |
$ | - | | |
$ | - | |
| |
| | | |
| | |
Non-Cash
Transactions | |
| | | |
| | |
Conversion
of convertible debt to Common Stock | |
$ | 369,286 | | |
$ | - | |
Derivative
liability adjustments to Additional Paid-In Capital | |
$ | 227,455 | | |
$ | - | |
The
accompanying notes are an integral part of these consolidated financial statements
Bowmo,
Inc. and Subsidiaries
Notes
to the Audited Consolidated Financial Statements
For
the Six Months Ended June 30, 2024 and 2023
NOTE
1 – BACKGROUND
Reverse Merger and Corporate Restructure
On
May 4, 2022, Cruzani, Inc. (“Cruzani” or the “Predecessor”) entered into a merger agreement (the “Merger
Agreement”) with Bowmo, Inc. (“Bowmo”) and Bowmo Merger Sub, Inc. to acquire Bowmo. (the “Acquisition”).
The transactions contemplated by the Merger Agreement were consummated on May 4, 2022, and pursuant to the terms of the Merger Agreement,
all outstanding shares of Bowmo were exchanged for shares of Cruzani’s common stock and Bowmo became Cruzani’s wholly
owned subsidiary.
The
merger was effected pursuant to the Merger Agreement. The merger is being accounted for as a reverse merger whereby Bowmo is the acquirer
for accounting purposes. Bowmo is considered the acquiring company for accounting purposes as upon completion of the Merger, Bowmo’s
former stockholders held a majority of the voting interest of the combined company.
Pursuant
to the merger, the Company issued Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities to
Bowmo’s stockholders. Upon completion of the acquisition, Bowmo is treated as the surviving entity and accounting acquirer although
Cruzani was the legal acquirer. Accordingly, the historical financial statements are those of Bowmo.
Accounting
for Reverse Merger
The
fair value of Cruzani assets acquired and liabilities assumed was based upon management’s estimates.
The
following table summarizes the allocation of purchase price of the acquisition:
Tangible
Assets Acquired: | |
Allocation | |
Cash
and cash equivalents | |
| 517 | |
Accounts
payable | |
| (326,400 | ) |
Accrued
interest | |
| (1,197,027 | ) |
Accrued
officer compensation | |
| (453,333 | ) |
Convertible
Notes | |
| (620,933 | ) |
Put
premium on stock settled debt | |
| (230,743 | ) |
Loans
payable | |
| (254,500 | ) |
Net
Tangible Assets Acquired | |
$ | (3,082,419 | ) |
| |
| | |
Equity
Acquired: | |
| | |
Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 shares issued and outstanding | |
| (33,815 | ) |
Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 shares issued and outstanding | |
| (50 | ) |
Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 shares issued and outstanding | |
| (50,000 | ) |
Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 shares issued and outstanding | |
| (12 | ) |
Series
E Preferred stock to be issued | |
| (166,331 | ) |
Series F Preferred stock, 101 shares authorized, par value $0.0001; 101 shares issued and outstanding | |
| - | |
Common stock 20,000,000,000 shares authorized, $0.00001 par value; 8,955,014,498 shares issued and outstanding | |
| (89,550 | ) |
Treasury stock, at cost – 2,917 shares | |
| 773,500 | |
Additional
paid in capital | |
| (2,648,676 | ) |
| |
| | |
Consideration: | |
| | |
Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities to Bowmo’s stockholders | |
| 1,000 | |
Organization
and Business
Bowmo,
Inc. (FKA Cruzani, Inc.) (the “Company”) is an AI-powered recruiting platform. The Company’s principal lines of business
are direct placement of candidates with employers and Recruiting as a Service which allows the Company’s customers to outsource
the management of their recruiting process to the Company. The Company offers recruiting software and services through an online AI-driven
platform to connect potential candidates to employers for all businesses looking to address hiring needs. The Company was incorporated
as a Delaware corporation in 2016.
NOTE
2 – GOING CONCERN
The
accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles which contemplate
continuation of the Company as a going-concern basis. The going concern basis assumes that assets are realized, and liabilities are extinguished
in the ordinary course of business at amounts disclosed in the consolidated financial statements. The Company has incurred recurring
losses from operations.
The
Company incurred a net loss for the six months ended June 30, 2024, of $691,086, of which approximately $376,606 was due to operations
and the remainder was due primarily to interest expense and derivative liabilities. At June 30, 2024, the Company has a working capital
deficit of $4,566,409 and an accumulated deficit of $13,682,963.
The
Company’s ability to continue as a going concern depends upon its ability to obtain adequate funding to support its operations
through continuing investments of debt and/or equity by qualified investors/creditors, internally generated working capital and monetization
of intellectual property assets. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
These consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as
a going concern. Management is currently pursuing a business strategy which includes raising the necessary funds to finance the Company’s
development and marketing efforts.
NOTE
3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States
of America (“GAAP”).The preparation of financial statements in conformity with accounting principles generally accepted in
the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates. Management further acknowledges that it is solely
responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing
and detecting fraud. The Company’s system of internal accounting control is designed to assure, among other items, that (1) recorded
transactions are valid; (2) valid transactions are recorded; and (3) transactions are recorded in the proper period in a timely manner
to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company for
the respective periods being presented.
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported
amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock,
stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred
tax assets. Actual results may differ from these estimates.
COVID-19
Impacts on Accounting Policies and Estimates
COVID-19
Impacts on Accounting Policies and Estimates In light of the currently unknown ultimate duration and severity of COVID-19, we face a
greater degree of uncertainty than normal in making the judgments and estimates needed to apply our significant accounting policies.
As COVID-19 continues to develop, we may make changes to these estimates and judgments over time, which could result in meaningful impacts
to our financial statements in future periods.
Principals
of Consolidation
The
consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP). The consolidated
financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions
have been eliminated.
Cash
and Cash Equivalents
The
Company accounts for cash and cash equivalents under FASB ASC 305, Cash and Cash Equivalents, and considers all highly liquid
investments with an original maturity of three months or less to be cash equivalents. At June 30, 2024 and December 31, 2023, the Company
had cash and cash equivalents of $12,517 and $6,308, respectively. There are no amounts that are uninsured by the FDIC (Federal Deposit
Insurance Corporation).
Deferred
Income Taxes and Valuation Allowance
We
recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial
statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted
tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to
reduce deferred tax assets to the amount expected to be realized. For the years ended December 31, 2023 and 2022, respectively,
due to cumulative losses, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the
period to zero. As of December 31, 2023 and 2022, we had no liabilities related to federal or state income taxes and the carrying value
of our deferred tax asset was zero.
The
Company accounts for income taxes applying FASB ASC 740, which requires the recognition of deferred tax liabilities and assets for expected
future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax
liabilities and assets are determined based on the difference between the financial statement and tax bases of assets and liabilities
using enacted tax rates in effect for the year in which the differences are expected to reverse.
Financial
Instruments
The
Company adopted the provisions of Accounting Standards Codification subtopic 825-10, Financial Instruments (“ASC 825-10”)
on January 1, 2008. ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets
and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in
which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent
risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize
the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels
of inputs that may be used to measure fair value:
Level
1 – Quoted prices in active markets for identical assets or liabilities.
Level
2 – Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets
with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs
are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets
or liabilities.
Level
3 – Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.
All
items required to be recorded or measured on a recurring basis are based upon level 3 inputs. To the extent that valuation is based
on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In
certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure
purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest
level input that is significant to the fair value measurement.
Upon
adoption of ASC 825-10, there was no cumulative effect adjustment to beginning retained earnings and no impact on the financial statements.
The
carrying value of the Company’s cash and cash equivalents, accounts receivable, accounts payable, short-term borrowings (including
convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.
Convertible
Instruments
The
Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with various accounting standards.
ASC
480 “Distinguishing Liabilities From Equity” provides that instruments convertible predominantly at a fixed rate resulting
in a fixed monetary amount due upon conversion with a variable quantity of shares (“stock settled debt”) be recorded as a
liability at the fixed monetary amount.
ASC
815 “Derivatives and Hedging” generally provides three criteria that, if met, require companies to bifurcate conversion options
from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances
in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the
economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument
and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes
in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument
would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is
deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”
The
Company accounts for convertible instruments (when it has determined that the instrument is not a stock settled debt and the embedded
conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting
for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible
Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion
options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment
date of the note transaction and the effective conversion price embedded in the note. Discounts under these arrangements are amortized
over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for
the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying
common stock at the commitment date of the share transaction and the effective conversion price embedded in the preferred shares.
ASC
815-40 provides that generally if an event is not within the entity’s control and could require net cash settlement, then the contract
shall be classified as an asset or a liability.
Convertible
Notes with Fixed Rate Conversion Options
The
Company may enter into convertible notes, some of which contain, predominantly, fixed rate conversion features, whereby the outstanding
principal and accrued interest may be converted by the holder, into common shares at a fixed discount to the market price of the common
stock at the time of conversion. This results in a fair value of the convertible note being equal to a fixed monetary amount. The Company
records the convertible note liability as stock settled debt in accordance with ASC 480 - “Distinguishing Liabilities from Equity”
and measures the convertible note at its fixed monetary amount, which is the result of the share price discount at the time of conversion,
and records the put premium, as applicable, on the note date with a charge to interest expense.
Derivative
Instruments
The
Company’s derivative financial instruments consist of derivatives with the sale of a convertible notes in 2024 and 2023. The accounting
treatment of derivative financial instruments requires that the Company records the derivatives at their fair values as of the inception
date of the debt agreements and at fair value as of each subsequent balance sheet date. The carrying value assigned to the host instrument
will be the difference between the previous carrying value of the host instrument and the fair value of the derivatives. There is an
offsetting debt discount or premium as a result of the fair value assigned to the derivatives, as well as any debt issuance costs, which
are amortized under the straight-line method over the term of the loan. Any change in fair value is recorded as non-operating, non-cash
income or expense at each balance sheet date. If the fair value of the derivatives was higher at the subsequent balance sheet date, the
Company recorded a non-operating, non-cash charge. If the fair value of the derivatives was lower at the subsequent balance sheet date,
the Company recorded non-operating, non-cash income.
Business
Combinations
The
Company accounts for its business combinations using the acquisition method of accounting. Under the acquisition method, assets acquired,
liabilities assumed, and consideration transferred are recorded at the date of acquisition at their respective fair values. Definite-lived
intangible assets are amortized over the expected life of the asset. Any excess of the purchase price over the estimated fair values
of the net assets acquired is recorded as goodwill.
Goodwill
represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination.
Acquisition-related expenses are recognized separately from business combinations and are expensed as incurred. The Company remeasures
fair value as of each reporting date and changes resulting from events after the acquisition date, are recognized as follows: 1) if the
contingent consideration is classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted
for within equity, or 2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs
are recognized in earnings.
Revenue
Recognition
For
annual reporting periods after December 15, 2017, the Financial Accounting Standards Board (“FASB”) made effective ASU 2014-09
Revenue from Contracts with Customers, to supersede previous revenue recognition guidance under current U.S. GAAP. Revenue is
now recognized in accordance with FASB ASC Topic 606, Revenue Recognition. The objective of the guidance is to establish the principles
that an entity shall apply to report useful information to users of financial statements about the nature, amount, timing, and uncertainty
of revenue and cash flows arising from a contract with a customer. The principle is to recognize revenue to depict the transfer of promised
services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those
services. Two options were made available for implementation of the standard: the full retrospective approach or modified retrospective
approach. The guidance became effective for annual reporting periods beginning after December 15, 2017, including interim periods within
that reporting period, with early adoption permitted.
The
Company generates revenue from (1) Recruiting as a Service (“Raas”), and (2) Direct Placement.
Recruiting
as a Service:
RaaS
allows the Company’s customers to outsource the management of their recruiting process allowing the Company to use the Application
to assist its customers hiring needs by strategically gearing the service to reach the customer’s objectives. Revenue from RaaS
consists of monthly billing to the customer for services provided.
RaaS
service contracts with customers are month-to-month for a fixed price. Revenues are recognized on a gross basis when each monthly subscription
service is completed.
Direct
Placement
The
Company generates direct placement revenue by earning one-time fees for each time an employer hires one of the candidates that the Company
refers. The Company sources qualified candidate referrals for the employers’ available jobs through the use of the Company’s
Application. Upon the employer hiring one or more of the Company’s candidate referrals, the Company earns the direct placement
fee, which consists of an amount agreed upon between the Company and its customers. The fee is a percentage of the referred candidates’
first year’s base salary.
Direct
placement revenues are recognized on a gross basis on the date of hire of the candidate placed with an employer, as it is more than
probable that a significant revenue reversal will not occur. This fee is only charged to the employer. Any payments received prior
to the hire date are recorded as deferred revenue on the consolidated balance sheets. Payments for recruitment services are
typically due within 30 days of completion of services.
Direct
placement revenue is subject to a 90-180 day guarantee that the candidate will not resign or be terminated in that time period. The
Company uses historical evidence as well as additional factors to determine and estimate the amount of consideration received that
the Company does not expect to be entitled to. For any amounts received for which the Company does not expect to be entitled, it
would not recognize revenue when the candidate is hired but would recognize those amounts received as a refund liability. The
Company included in the transaction price the estimated amount of variable consideration per the expected value method. A refund
liability would be credited for the difference between cash consideration received and variable consideration recognized. The refund
liability would be updated at the end of each reporting period for any changes in circumstances. As of December 31, 2023 and 2022
there was no refund liability on the consolidated balance sheets as historically no direct placement revenue has
been refunded to the Company.
Revenue
Segementation
For
six months ended June 30, 2024, and June 30, 2023, revenues can be categorized into the following:
|
|
June
30,
2024 |
|
|
June
30,
2023 |
|
|
|
|
|
|
|
|
Direct placement |
|
$ |
- |
|
|
$ |
4,476 |
|
Recruiting as a Service |
|
|
- |
|
|
|
- |
|
Total revenues |
|
$ |
- |
|
|
$ |
4,476 |
|
Cost
of revenues
Cost
of revenue consist of employee costs, third party staffing costs, hosting service fees, and other fees, outsourced recruiter fees and
commissions.
Concentrations
of credit risk
Financial
instruments which potentially subject the Company to credit risks consist primarily of cash and cash equivalents, and accounts receivable.
Cash and cash equivalents are held in United States financial institutions. At times such amounts may exceed federally insured limits.
Stock-based
compensation
We
account for our stock-based compensation under ASC 718 “Compensation - Stock Compensation” using the fair value based method.
Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the shorter
of the service period or the vesting period of the stock-based compensation. This guidance establishes standards for the accounting for
transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity
incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that
may be settled by the issuance of those equity instruments. The Company estimates the fair value of each stock option at the grant date
by using the Black-Scholes option pricing model. Determining the fair value of stock-based compensation at the grant date under this
model requires judgment, including estimating volatility, employee stock option exercise behaviors and forfeiture rates. The assumptions
used in calculating the fair value of stock-based compensation represent the Company’s best estimates, but these estimates involve
inherent uncertainties and the application of management judgment.
Recently
Issued Accounting Pronouncements
We
have reviewed the FASB issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that
have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements
that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material
impact on the corporation’s reported financial position or operations in the near term. The applicability of any standard is subject
to the formal review of our financial management and certain standards are under consideration.
Change
in account principle
Commencing
with the second quarter of 2022, the Company prospectively changed its accounting treatment for securities that contain predominantly,
fixed rate conversion features by recording the derivative feature as a put premium on stock settled debt. See Note 7 for further
discussion. The company believes this change in accounting principle is preferable as it applies a more consistent method of accounting
for convertible notes that contain similar conversion features.
NOTE
4 – BUSINESS COMBINATIONS
Interview
Mastery Asset Purchase
On
December 16, 2022, the Company entered into an Asset Purchase Agreement (the “APA”) with a related party, Interview Mastery
Corporation (“Interview Mastery”), a Delaware corporation, by and through Michael R. Neece (“Neece”), the Company’s
Chief Product Officer, and Caseridus, Inc. Under the terms of the APA, the Company will pay the purchase price through the issuance of
1,000,000,000 (pre-reverse split) shares of the Company’s common stock to the stockholders of Interview Mastery, valued at the
stock price of $0.0002 on the acquisition date, that vest immediately for all of the business assets of Interview Mastery. An additional
1,000,000,000 (pre-reverse split) shares of Company common stock will be issued as compensation in consideration of Neece’s employment
with the Company which shall vest over a four (4) year period during which 250,000,000 (pre-reverse split) shares will vest on the first-year
anniversary of Neece’s employment, followed by vesting in increments of 62,500,000 shares per quarter (3-month period) thereafter
until the full amount is vested and all of which shall be contingent upon Neece’s continual employment with the Company. These
shares were valued using the share price of $0.0002 at the date of acquisition, and they will be expensed as stock-based compensation
based on the vesting terms contingent upon continual employment of Neece. In connection with the APA, the Company created a new board
seat and offered this seat to Neece who was formally invited to join the Company’s Board of Directors.
The
acquisition was accounted for as a business combination in accordance with the acquisition method under the guidance in ASC 805-10 and
805-20. This business combination was accounted for as a related party acquisition, as Neece is the chief product officer of the Company.
Accordingly,
the total purchase consideration was allocated to net assets acquired based on their respective historical costs. The assets acquired,
and liabilities assumed, if any, in a business purchase combination be recognized at their historical costs as of the acquisition date.
The
final allocation of the purchase price in connection with the Interview Mastery acquisition was calculated as follows:
Description | |
Fair
Value | | |
Weighted
Average Useful Life (Years) | |
Cash | |
$ | 1,633 | | |
| | |
Prepaid expenses | |
| 997 | | |
| | |
Loss on acquisition
– related party | |
| 197,370 | | |
| | |
| |
$ | 200,000 | | |
| | |
Total
acquisition costs incurred were $58,092 recorded as a component of General and administrative expenses. As a result of the business combination,
the Company recognized a related party loss of $197,370 which is included in general and administrative expenses on the consolidated
statements of operations during the year ended December 31, 2022.
Pro
Forma Information
The
results of operations of Interview Mastery will be included in the Company’s consolidated financial statements as of the date of
acquisition through the current period end. The following supplemental pro-forma financial information approximate combined financial
information assumes that the acquisition had occurred at the beginning of the years ended December 31, 2022 and 2021:
| |
December 31, | | |
December 31, | |
| |
2022 | | |
2021 | |
Revenue | |
$ | 198,982 | | |
$ | 216,367 | |
Net Loss | |
$ | (4,595,717 | ) | |
$ | (287,779 | ) |
Earnings (Loss) per common share, basic and
diluted | |
$ | - | | |
$ | (0.02 | ) |
NOTE
5 – LOANS PAYABLE
As
a result of the reverse merger that occurred on May 4, 2022, as discussed in Note 1, the Company assumed Loans 1 through 5 on the table
below from Cruzani.
The
Cruzani loan payable balances are as follows:
|
|
Rate |
|
|
June
30,
2024 |
|
|
December
31,
2023 |
|
Loan 1 |
|
|
1 |
% |
|
$ |
42,000 |
|
|
$ |
27,000 |
|
Loan 2 |
|
|
1 |
% |
|
|
3,000 |
|
|
|
3,000 |
|
Loan 3 |
|
|
8 |
% |
|
|
64,000 |
|
|
|
64,000 |
|
Loan 4 |
|
|
8 |
% |
|
|
160,500 |
|
|
|
160,500 |
|
Loan 5 |
|
|
|
|
|
|
- |
|
|
|
- |
|
Total |
|
|
|
|
|
$ |
269,500 |
|
|
$ |
254,500 |
|
Annual maturities
of the Cruzani notes payable are as follows:
For the
year ending | |
Amount | |
December 31, 2024 | |
| 6,807 | |
December 31, 2025 | |
| 7,066 | |
December 31, 2026 | |
| 7,336 | |
December 31, 2027 | |
| 7,616 | |
Thereafter | |
| 240,675 | |
Total payments | |
$ | 269,500 | |
Loans
1 through 5 are past due as of the issuance of these financial statements.
Loan
1) On May 30, 2013, and August 12, 2013, Cruzani received advances from a director for $2,000 and $25,000, respectively. On August 12,
2013, the Company entered into an unsecured, non-guaranteed, demand loan agreement with the director for $27,000. The loan bears interest
at 1% per annum compounded monthly.
Loan
2) On February 27, 2014, and March 19, 2015, Cruzani received advances from a director of $6,000, and $10,200, respectively. During the
year ended December 31, 2015, the Company repaid $13,200. The advances are unsecured, due on demand and bears interest at 1% per annum
compounded and calculated monthly.
Loan
3) On September 18, 2014, May 29, 2015, July 3, 2015, December 2, 2015, and January 4, 2016, Cruzani entered into unsecured, non-guaranteed,
loan agreements pursuant to which the Company received proceeds of $35,000, $4,000, $5,000, $22,000, and $45,000, respectively. The loans
bear interest at 8% per annum compounded annually and are due 1 year after the date of issuance.
Loan
4) On December 4, 2014, January 29, 2015, August 12, 2015, August 21, 2015, September 1, 2015, September 15, 2015, November 13, 2015,
and December 23, 2015, Cruzani issued unsecured notes payable of $20,000, $20,000, $20,000, $25,000, $40,000, $25,000, $30,000 and
$10,000, respectively, to a significant shareholder. The notes bear interest at an annual rate of 8% per annum, are uncollateralized,
and due 1 year after the date of issuance.
Loan
5) Entities negatively impacted by the coronavirus (“COVID-19”) pandemic were eligible to apply for loans sponsored by the
United States Small Business Administration (“SBA”) Economic Injury Disaster Loan (“EIDL Loan”) program. On July
15, 2020, the Company received cash proceeds of $40,400 under this program. In addition, in July 2020, the Company received $6,000 from
the SBA as a COVID-19 Economic Injury Disaster Loan Advance (the “EIDL Advance”). The proceeds can be used to fund payroll,
healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL
Loan repayment terms include interest accruing at 3.75% per annum effective July 15, 2020; the payment schedule contains a one-year deferral
period on initial principal and interest payments; the loan term is thirty years; and there is no prepayment penalty or fees. The Company
pledged all assets of the Company as collateral for the loan. As of December 31, 2021, the amounts outstanding totaled $40,400, and was
classified as part of notes payable on the consolidated balance sheet. Additionally, the Company entered into a security agreement with
the SBA in which this promissory note is collateralized by all tangible and intangible assets of the Company. On January 6, 2021, the
SBA announced a one-year extension of the deferral period for loans that commenced in 2020 delaying payments of principal and interest
to July 2022. Pursuant to an SBA Procedural Notice in December 2020, the EIDL Advance was forgiven. The Company has recognized the entire
EIDL Advance amount of $6,000 as grant income, which is included in other income (expense) in the consolidated statement of operations
for the year ended December 31, 2021.
In
February 2022, the Company agreed to the first and second modifications of the EIDL Loan. The EIDL was modified to include additional
borrowings of $269,200, which were received in full in February 2022. Periodic monthly payments have increased to $1,556 in the first
modification, and reduced to $1,506 in the second modification. Additionally, the Company entered into an amended security agreement
with the SBA in which this promissory note, and the modifications, is collateralized by all tangible and intangible assets of the Company.
The balance of the EIDL loan balance at March 31, 2024, and December 31, 2023 $193,202 and $193,202, respectively.
NOTE
6 – CONVERTIBLE NOTES
The
following table summarizes the convertible notes as of June 30, 2024, and December 31, 2023:
| |
| | |
| | |
Put Premium | |
| |
June 30, | | |
December 31, | | |
On Stock | |
Creditor | |
2024 | | |
2023 | | |
Settled
Debt | |
Frondeur | |
$ | 16,083 | | |
$ | 123,793 | | |
$ | 16,083 | |
Kings Wharf | |
| 46,900 | | |
| 42,200 | | |
| - | |
1800 Diagonal Lending | |
| 152,000 | | |
| 117,000 | | |
| 40,000 | |
Trillium | |
| 124,000 | | |
| - | | |
| 124,000 | |
Matterhorn | |
| - | | |
| 8,454 | | |
| - | |
Travel Data Solutions | |
| - | | |
| 125,000 | | |
| - | |
Third
Party * | |
| 40,099 | | |
| 230,232 | | |
| 25,601 | |
Total | |
| 379,083 | | |
| 646,679 | | |
| 205,684 | |
Less:
Debt discount | |
| (273,330 | ) | |
| (206,570 | ) | |
| | |
Total
Convertible notes payable | |
$ | 105,753 | | |
$ | 440,109 | | |
| | |
Frondeur
Between
June 1, 2022 and December 1, 2022, the Company entered into several convertible notes with Frondeur Partners, LLC bearing interest at
10% per annum and totaling $160,000. These convertible notes are convertible between 50% and 70% of the lowest close bid price of the
Company’s stock price for a twenty day period. These convertible notes were accounted for as stock settled debt in
accordance with ASC 480 - “Distinguishing Liabilities from Equity”, resulting in put premiums on stock settled debt being
recognized. See Note 7. During the years ended December 31, 2023 and 2022,the lender opted to convert certain portions of the note into
shares of the Company’s common stock. Through March 31, 2024, the Company issued three convertible notes. The total principal amount
of these notes is $30,000. They bear interest at 12% and are due in full at October 31, 2024, November 30, 2024 and December 31, 2024,
respectively. Due to these conversions, the remaining principal balances at June 30, 2024, and December 31, 2023, was $16,083 and $123,793,
respectively.
Between
November 1, 2021 and May 1, 2022, Cruzani entered into several convertible notes with Frondeur Partners, LLC bearing interest at 10%
per annum and totaling $175,000. These convertible notes were convertible at 70% of the lowest close bid price of the Company’s
stock price for a twenty day period. These convertible notes were accounted for as stock settled debt in accordance with
ASC 480 - “Distinguishing Liabilities from Equity”, resulting in put premiums on stock settled debt being recognized. See
Note 7. As of December 31, 2022, these convertible notes were converted into shares of the Company’s common stock.
During
the three months ended March 31, 2024, the Company issued three additional convertible notes to Fondeur. The aggregate principal amount
of these notes is $30,000, and the notes are dated January 1, 2024 ($10,000), February 1, 2024 ($10,000) and March 1, 2024 ($10,000).
They bear interest at 12% and are due in full at October 31, 2024, November 30, 2024 and December 31, 2024, respectively. During Due
to these conversions, the remaining principal balances at June 30, 2024, and December 31, 2023, was $16,083 and $123,793, respectively.
The Company granted 150,000 warrants to purchase 150,000 shares of the Company’s common stock with these convertible notes. These
warrants have an exercise price of $0.0001 and a term of five years.
Kings
Wharf
On
October 19, 2022, the Company entered into a convertible note with King Wharf Opportunities Fund bearing interest at 8% totaling $275,000.
The note included an original issue discount of $25,000. This convertible note is convertible at the lesser of $0.0001 or 50% of the
lowest trading price of the Company’s stock price for a thirty day period. The embedded conversion option of the convertible
note contains conversion features that qualify for embedded derivative classification as a result of variable conversion price features,
which is not a fixed discount rate. See Note 8. This convertible note is fully guaranteed by the Company’s Chief Executive Officer,
Eddie Aizman, and President, Michael Lakshin. Additionally, on October 19, 2022, both Mr., Aizman and Mr. Lakshin, entered into pledge
agreements in which they each have agreed to secure the Company’s payment obligations to the lender with a guaranty and a pledge
of 163,461 shares of Series G preferred stock of the Company, for a total of 326,922 shares of Series G Preferred Stock. During the years
ended December 31, 2023 and 2022, the lender opted to convert certain portions of the note into shares of the Company’s common
stock. Due to these conversions, the remaining principal balances at June 30, 2024, and December 31, 2023, was $46,900 and $42,200, respectively.
1800
Diagonal Lending
November
10, 2023, the Company entered into a convertible note with 1800 Diagonal Lending bearing interest at 10% totaling $77,000. This convertible
note is convertible at the lesser of $0.0001 or 61% of the lowest trading price of the Company’s stock price for a thirty-day period.
The embedded conversion option of the convertible note contains conversion features that quality for embedded derivative classification
as a result of variable conversion price features, which is not a fixed discount rate. The outstanding remaining principal balances at
June 30, 2024, and December 31, 2023, was $112,000 and $77,000, respectively.
December
12, 2023, the Company entered into a convertible note with 1800 Diagonal Lending bearing interest at 10% totaling $40,000. This convertible
note is convertible at the lesser of $0.0001 or 61% of the lowest trading price of the Company’s stock price for a thirty-day period.
The embedded conversion option of the convertible note contains conversion features that quality for embedded derivative classification
as a result of variable conversion price features, which is not a fixed discount rate. The outstanding remaining principal balances at
June 30, 2024, and December 31, 2023, was $40,000 and $40,000, respectively.
During
the six months ended June 30, 2024, the Company entered into a convertible note with 1800 Diagonal Lending bearing interest at 10% totaling
$35,000. This convertible note is convertible at the lesser of $0.0001 or 61% of the lowest trading price of the Company’s stock
price for a thirty-day period. The embedded conversion option of the convertible note contains conversion features that quality for embedded
derivative classification as a result of variable conversion price features, which is not a fixed discount rate. The outstanding remaining
principal balances at June 30, 2024, and December 31, 2023, was $35,000 and $0, respectively.
Trillium
Between
May 25, 2021 and July 6, 2021, Cruzani entered into two convertible notes with Trillium Partners, LP bearing interest at 10% per annum
and totaling $44,000. These convertible notes were convertible at a fixed price of $0.0001. During the years ended December 31,
2023 and 2022, the lender opted to convert certain portions of the note into shares of the Company’s common stock. Due to these
conversions, the remaining principal balances at June 30, 2024, and December 31, 2023, was $0 and $0.
Between
June 1, 2022 and December 6, 2022, the Company entered into several convertible notes with Trillium Partners, LP bearing interest between
10% and 12% per annum and totaling $332,800. These convertible notes are convertible at a fixed price between $0.0001 and $0.0002.
During the years ended December 31, 2023 and 2022, the lender opted to convert certain portions of the note into shares of the Company’s
common stock. Due to these conversions, the remaining principal balances at June 30, 2024, and December 31, 2023, was $0 and $0, respectely.
On
October 19, 2022, the Company entered into a convertible note with Trillium Partners, LP bearing interest at 8% totaling $275,000. The
note included an original issue discount of $25,000. This convertible note is convertible at the lesser of $0.0001 or 50% of the lowest
trading price of the Company’s stock price for a thirty day period. The embedded conversion option of the convertible note
contains conversion features that qualify for embedded derivative classification as a result of variable conversion price features, which
is not a fixed discount rate. See Note 8. This convertible note is fully guaranteed by the Company’s Chief Executive Officer, Eddie
Aizman, and President, Michael Lakshin. Additionally, on October 19, 2022, both Mr., Aizman and Mr. Lakshin, entered into pledge agreements
in which they each have agreed to secure the Company’s payment obligations to the lender with a guaranty and a pledge of 163,461
shares of Series G preferred stock of the Company, for a total of 326,922 shares of Series G Preferred Stock. During the years ended
December 31, 2023 and 2022, the lender opted to convert certain portions of the note into shares of the Company’s common stock.
Due to these conversions, the remaining principal balances at June 30, 2024, and December 31, 2023, was $62,000 and $0, respectively.
During
the six months ended June 30, 2024, the Company entered into four additional convertible notes with Trillium Partners, LP bearing interest
of 10% to 12% totaling $62,000. These notes include original issue discounts totaling $7,000. These note have 6 months maturity dates
and are convertible at the lesser of $0.0001 or 50% of the lowest trading price of the Company’s stock price for a thirty
day period. The embedded conversion option of the convertible note contains conversion features that qualify for embedded derivative
classification as a result of variable conversion price features, which is not a fixed discount rate. The remaining principal balances
at June 30, 2024, and December 31, 2023, was $62,000 and $0, respectively.
Matterhorn
On
August 15, 2023, the Company entered into a convertible note with Matterhorn Partners LLC bearing interest at 12% totaling $25,000. The
note included an original issue discount of $4,000. This convertible note is convertible at the lesser of $0.0001 or 50% of the lowest
trading price of the Company’s stock price for a thirty-day period. The embedded conversion option of the convertible note contains
conversion features that quality for embedded derivative classification as a result of variable conversion price features, which is not
a fixed discount rate. This convertible note is fully guaranteed by the Company’s Chief Executive Officer, Eddie Aizman and President,
Michael Lakshin. During the years ended December 31, 2023 and 2022, the lender opted to convert certain portions of the note into shares
of the Company’s common stock. Due to these conversions, the remaining principal balances at June 30, 2024, and December 31, 2023,
was $ 0 and $8,454, respectively.
Travel
Data Solutions
On
November 18, 2017, Cruzani entered into a convertible promissory note for $25,000 with Travel Data Solutions, Inc., pursuant to which
the Company received proceeds of $25,000. The notes are convertible at any time after September 13, 2018 at a mutually agree upon conversion
price, bearing interest rate at 10% per annum and due on November 30, 2019. During January and February 2018, the Company received an
additional $75,000 under the same terms as the previously issued convertible promissory note. During the year ended December 31, 2023,
the balance of the note was converted into shares of the Company’s common stock. As of June 30, 2024, and December 31, 2023, the
outstanding balance was $ 0 and $125,000, respectively.
Third
Party
As
a result of the reverse merger that occurred on May 4, 2022, as discussed in Note 1, the Company assumed convertible notes from Cruzani
(1-3 below). Convertible debt outstanding during the three months ended March 31, 2024, and the year ended December 31, 2023, consist
of the following:
| 1) | Between May 20, 2020 and October 1, 2021, Cruzani entered into several convertible notes with Livingston Asset Management bearing interest at 10% per annum and totaling $331,600. These convertible notes were convertible at 70% of the lowest close bid price of the Company’s stock price for a twenty day period. These convertible notes were accounted for as stock settled debt in accordance with ASC 480 - “Distinguishing Liabilities from Equity”, resulting in put premiums on stock settled debt being recognized. As of December 31, 2022, these convertible notes were converted into shares of the Company’s common stock. |
| 2) | On November 17, 2021, Cruzani entered into a convertible note with Oscaleta Partners, LLC bearing interest at 10% per annum and totaling $11,000. This convertible note was convertible at 50% of the lowest close bid price of the Company’s stock price for a twenty day period. This convertible note was accounted for as stock settled debt in accordance with ASC 480 - “Distinguishing Liabilities from Equity”, resulting in a put premium on stock settled debt being recognized. As of December 31, 2022, the convertible note was converted into shares of the Company’s common stock. |
| 3) | On July 7, 2020, the Company issued a $84,681 convertible promissory note to a third party in exchange for $84,681. The Convertible Note bears interest at 10%, per annum. All unpaid principal and accrued interest under the Convertible Note will be due and payable in full one year from issuance. After six months from the issuance date, the Holder may elect to convert into that number of shares of common stock equal to the quotient obtained by dividing the outstanding principal balance and unpaid accrued interest under this Note by the amount equal to the anticipate public market price of the Company’s common stock multiplied by fifty percent (50%). This convertible note was accounted for as stock settled debt in accordance with ASC 480 - “Distinguishing Liabilities from Equity”, resulting in put premiums on stock settled debt being recognized. See Note 7. As of December 31, 2022, this convertible note is in default and the principal and accrued interest balance remain outstanding. During the year ended December 31, 2023, the Company had additional borrowings of $6,728. As of June 30, 2024, and December 31, 2023, the outstanding balance was $40,099 and $230,232, respectively |
NOTE
7 – PUT PREMIUM ON STOCK SETTLED DEBT
At
the end of the quarter ended June 30, 2022, the Company decided to adopt ASC 480- “Distinguishing Liabilities from Equity.”
When they enter into convertible notes, some of which contain, predominantly, fixed rate conversion features (See Note 7 for conversion
terms), whereby the outstanding principal and accrued interest may be converted by the holder, into common shares at a fixed discount
to the market price of the common stock at the time of conversion. This results in a fair value of the convertible note being equal to
a fixed monetary amount. The Company records the convertible note liability at its fixed monetary amount by measuring and recording a
put premium on the consolidated balance sheets, as applicable, on the note date with a charge to interest expense.
The
put premiums are expensed on issuance of the debt with the liability released to additional paid in capital on conversion of the principal.
In
previous years, the Company had recorded such items as derivative liabilities (See Note 8). Thus, there was a charge to put premium
on stock settled debt and a decrease to derivative liability for all convertible debt determined to have fixed rate conversion
options. On a going-forward basis, all put premiums will be recorded as a liability as put premium on stock settled debt on the
consolidated balance sheets with a charge to interest expense.
The
company believes this change in accounting principles in preferable as it applies a more consistent method of accounting for convertible
notes that contain similar conversion features. This accounting change resulted in a gain on new methodology for accounting for debt
conversion features of $0 and $27,856 on the statement of operations for the years ended December 31, 2023 and December 31, 2022, respectively.
NOTE
8 – DERIVATIVE LIABILITIES
Commencing
with the second quarter of 2022, the Company changed its accounting treatment for securities that contain predominantly, fixed rate conversion
features by recording the derivative feature as a put premium on stock settled debt.
The
embedded conversion options of certain of the Company’s convertible debentures summarized in Note 6 contain variable conversion
features that qualify for embedded derivative classification under ASC 815-15 Embedded Derivatives. The fair value of these liabilities
is re-measured at the end of every reporting period and the change in fair value is reported in the statement of operations as a gain
or loss on derivative financial instruments.
The
table below sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities:
| |
Total | |
Balance as of December 31, 2021 | |
$ | 110,992 | |
Change Due to Issuances | |
| 2,718,645 | |
Transfer to put premium | |
| (112,537 | ) |
Change in fair value | |
| (544,850 | ) |
Balance as of December 31, 2022 | |
| 2,172,250 | |
Change Due to Issuances | |
| (4,035,300 | ) |
Transfer to put premium | |
| 651,156 | |
Change in fair value | |
| 1,645,712 | |
Balance as of December 31, 2023 | |
| 433,818 | |
Change in fair value | |
| 144,545 | |
Balance as of June 30,
2024 | |
$ | 578,363 | |
The
Company uses Level 3 inputs for its valuation methodology for its conversion option liabilities as their fair values were determined
by using Black-Scholes options pricing model. The option-pricing model requires a number of assumptions, of which the most significant
are share price, expected volatility and the expected option term (the time from the issuance date until the maturity date). The Company
has historically not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield
from governmental zero-coupon bonds with an equivalent term. As, required, these are classified based on the lowest level of input that
is significant to the fair value measurement.
The
following table shows the assumptions used in the calculations of its derivatives:
| |
| June
30,
2024 | | |
| December
31,
2023 | |
Stock price | |
| $0.0001 - $0.1500 | | |
| $0.0001 - $0.1500 | |
Exercise price | |
| $0.00003 - $0.2572 | | |
| $0.00003 - $0.2572 | |
Contractual term (in years) | |
| 7.00 – 0.025 | | |
| 7.00 – 0.025 | |
Volatility (annual) | |
| 174% - 2068% | | |
| 174% - 2068% | |
Risk-free rate | |
| 4.41% - 5.57% | | |
| 4.41% - 5.57% | |
NOTE
9 – RELATED PARTY TRANSACTIONS
For
the six months ended June 30, 2024, and the year ended December 31, 2023, expenses of $9,693 and $38,771 were incurred for recruitment
services by an entity owned by Michael Neece, Chief Product Officer.
Per
the agreement with Michael Neece, a salary of $12,500 and a bonus of $4,167 was accrued for the year ended December 31, 2022. For the
year ended December 31, 2023, an additional $150,000 in salary and a bonus of $50,000 was accrued. For the six months ended June 30,
2024, an additional $75,000 in salary was accrued.
On
December 16, 2022, Bowmo, Inc. (the “Company”) entered into an Asset Purchase Agreement (the “APA”) with a related
party, Interview Mastery Corporation (“Interview Mastery”), a Delaware corporation, by and through Michael R. Neece (“Neece”)
and Caseridus, Inc. Michael Neece, the seller of Interview Mastery, is the chief product officer of the Company.
Through
June 30, 2024, the Company owed Eddie Aizman and Michael Lakshin compensation based on their employment agreements; the agreements provide
for annual salaries of $180,000 and $200,000, respectively commencing on September 6, 2022. During the year ended December 31, 2022,
salaries of $57,205 and $63,562, were accrued for Eddie Aizman and Michael Lakshin, respectively. During the six months ended June 30,
2024, and the year ended December 31, 2023, salaries of $180,000 and $200,000, were accrued for Eddie Aizman and Michael Lakshin, respectively
on an annualized basis. As of June 30, 2024, the total due to Eddie Aizman and Michal Lakshin is $327,205 and $363,562, respectively.
On
July 8, 2019, the Company executed an employment agreement with Conrad Huss. The agreement provides for a salary of $10,000 per month.
As of June 30, 2024, no additional amounts have been credited to accrued compensation.
NOTE
10 – COMMON STOCK
The
Company has been authorized to issue 40,000,000,000 shares of common stock, $0.00001 par value. Each share of issued and
outstanding common stock shall entitle the holder thereof to fully participate in all shareholder meetings, to cast one vote
on each matter with respect to which shareholders have the right to vote, and to share ratably in all dividends and other distributions
declared and paid with respect to common stock, as well as in the net assets of the corporation upon liquidation or dissolution.
During
the year ended December 31, 2022, the Company issued 18,094,721,962 (pre-reverse split) shares of common stock for the extinguishment
of convertible debt.
During
the year ended December 31, 2023, the Company issued 6,364,768,689 (post-reverse split) shares of common stock for the extinguishment
of convertible debt.
During
the three and six months ended June 30, 2024, the Company issued 53,520,730 and 82,937,180 shares of common stock respectively for the
extinguishment of convertible debt.
As
of June 30, 2024, the Company had 136,458,010 shares of common stock outstanding.
Acquisition
of Interview Mastery
As
discussed in Note 4, on December 16, 2022, the Company acquired Interview Mastery at a purchase price of 1,000,000,000 (pre-reverse split)
shares of the Company’s common stock, valued at $200,000 using the stock price on the acquisition date. As of June 30, 2024 and
December 31, 2023, these shares have not been issued and are recorded as a liability within accrued expenses on the consolidated balance
sheet.
Michael
Neece employment agreement
On
December 16, 2022, the Company entered into an employment agreement with Michael Neece, Chief Product Officer. Under the agreement, 1,000,000,000
(pre-reverse split) shares of Company common stock will be issued as compensation in consideration of Neece’s employment with the
Company which shall vest over a four (4) year period during which 250,000,000 (pre-reverse split) shares will vest on the first-year
anniversary of Neece’s employment, followed by vesting in increments of 62,500,000 (pre-reverse split) shares per quarter (3-month
period) thereafter until the full amount is vested and all of which shall be contingent upon Neece’s continual employment with
the Company. These shares were valued using the share price of $0.0002 at the date of acquisition, and they will be expensed as stock-based
compensation based on the vesting terms contingent upon continual employment of Neece. As of December 31, 2023 and December 31, 2022,
250,000 and 0 shares have vested, respectively.
NOTE
11 – WARRANTS
In
connection with the issuance of convertible notes to Trillium and Fondeur, the Company issued 38,650,000 post-reverse split) common
stock purchase warrants to purchase 38,650,000 shares of the Company’s common stock pursuant to the terms therein as a commitment
fee. During the three months ended March 31, 2024, the Company, in connection with the three additional notes issued to Fondeur, granted
the issuance of an additional 150,000 warrants to purchase 150,000 shares of the Company’s common stock.
These
warrants have an exercise price per share between $0.025- $0.0010 the above and expire between five and seven years. The aggregate fair
value of the warrants, which was allocated against the debt proceeds totaled $596,927 based on the Black Scholes Merton pricing
model using the following estimates: exercise price ranging from $0.00025 and $0.0025, 2.50% to 4.28% risk free rate, 266.74%
to 699.48% volatility and expected life of the warrants of 5 to 7 years. The fair value was credited to additional
paid in capital and debited to debt discount to be amortized over the term of the loan.
A
summary of the status of the Company’s outstanding stock warrants and changes during the periods is presented below:
| | Shares available to purchase with warrants* | | | Weighted Average Price | | | Weighted Average Remaining life | |
Outstanding, December 31, 2023 | | | 38,650,000 | | | $ | 0.001 | | | $ | 6.54 | |
| | | | | | | | | | | | |
Issued | | | 39,150,000 | | | | 0.001 | | | | - | |
Exercised | | | - | | | | - | | | | - | |
Forfeited | | | - | | | | - | | | | - | |
Expired | | | - | | | | - | | | | - | |
Outstanding, June 30, 2024 | | | 77,800,000 | | | $ | 0.001 | | | $ | 6.45 | |
| | | | | | | | | | | | |
Exercisable, June 30, 2024 | | | 77,800,000 | | | $ | 0.001 | | | $ | 6.45 | |
The
Company uses Level 3 inputs for its valuation methodology for its conversion option liabilities as their fair values were determined
by using the Binomial option pricing model based on various assumptions. The model incorporates the price of a share of the Company’s
common stock (as quoted on the Over the Counter Bulletin Board), volatility, risk free rate, dividend rate and estimated life. Significant
changes in any of these inputs in isolation would result in a significant change in the fair value measurement. As, required, these are
classified based on the lowest level of input that is significant to the fair value measurement. The following table shows the assumptions
used in the calculations:
Range of Exercise Prices | | Number Outstanding June 30, 2024 | | | Weighted Average Remaining Contractual Life | | Weighted Average Exercise Price | |
$0.025-0.0010 | | | 77,800,000 | | | 6.45 years | | $ | 0.0001 | |
NOTE
12 – PREFERRED STOCK
Series
AA and Super Convertible Preferred Stock, has a par value of $0.001, may be converted at the holder’s election into shares
of common stock at the conversion rate of one share of common stock for one share of Preferred Stock.
As
of June 30, 2024, and December 31, 2023, there are 0 and 0 shares of Series AA and Super preferred stock outstanding, respectively.
Series
A Convertible Preferred Stock, has a par value of $0.01, may be converted at the holder’s election into shares of common
stock at the conversion rate of ten shares of common stock for one share of Series A Preferred Stock. Each share is entitled to 10 votes,
voting with the common stock as a single class, has liquidation rights of $2.00 per share and is not entitled to receive dividends.
As
of June 30, 2024, and December 31, 2023, there are 3,381,520 and 3,381,520 shares of Series A preferred stock outstanding, respectively.
Series
B Convertible Preferred Stock, has a par value of $0.01, may be converted at the holder’s election into shares of common
stock at the conversion rate of 4,000 shares of common stock for one share of Series B Preferred Stock. Each share is entitled to 4,000
votes, voting with the common stock as a single class, has liquidation rights of $0.01 per share and is not entitled to receive dividends.
As
of June 30, 2024, and December 31, 2023, there are 5,000 and 5,000 shares of Series B preferred stock outstanding, respectively.
Series
C Convertible Preferred Stock, has a par value of $0.01, may be converted at the holder’s election into shares of common
stock at the conversion rate of 400 shares of common stock for one share of Series C Preferred Stock. Each share is entitled to 400 votes,
voting with the common stock as a single class, has liquidation rights of $0.01 per share and is entitled to receive four hundred times
the dividends declared and paid with respect to each share of Common Stock.
As
of June 30, 2024, and December 31, 2023, there are 5,000,000 and 5,000,000 shares of Series C preferred stock outstanding, respectively.
Series
D Convertible Preferred Stock, has a par value of $0.0001, may be converted at a ratio of the Stated Value plus dividends accrued
but unpaid divided by the fixed conversion price of $0.0015, which conversion price is subject to adjustment. Series D is non-voting,
has liquidation rights to be paid in cash, before any payment to common or junior stock, 140% of the Stated Value ($2.00) per share plus
any dividends accrued but unpaid thereon and is entitled to 8% cumulative dividends.
As
of June 30, 2024, and December 31, 2023, there are 125,000 and 125,000 shares of Series D preferred stock outstanding, respectively.
Series
E Convertible Preferred Stock, has a par value of $0.001, and a stated value of $1.00 per share, subject to adjustment. The shares
of Series E Convertible Preferred Stock can convert at a conversion price that is equal to the amount that is 61% of the lowest trading
price of the Company’s common stock during the 20 trading days immediately preceding such conversion. The shares of Series E Convertible
Preferred Stock are subject to redemption by the Company at its option from the date of issuance until the date that is 180 days therefrom,
subject to premium that ranges from 120% to 145%, increasing by 5% during each 30-day period following issuance. Series E carries a 12%
cumulative dividend, which will increase to 22% upon an event of default, is non-voting, and has liquidation rights to be paid in cash,
before any payment to common or junior stock.
Series
F Convertible Preferred Stock, has a par value of $0.001, may be converted at the holder’s election into shares of common
stock at the current conversion rate of 93,761,718 shares of common stock for one share of Series F Preferred Stock. Each share is entitled
to 93,761,718 votes, voting with the common stock as a single class, has no liquidation rights and is not entitled to receive dividends.
As
of June 30, 2024, and December 31, 2023, there are 0 and 0 shares of Series F preferred stock issued, respectively.
Series
G Convertible Preferred Stock, has a par value of $0.001, may be converted at the holder’s election into shares of common
stock for a period ending 18 months following issuance at the conversion rate that will result, in the aggregate, in the holders of Series
G Preferred Stock receiving that number of shares of Common Stock which equals Seventy Eight Percent (78%) of the total issued and outstanding
shares of commons stock of the company on a fully diluted basis. The Series G Preferred Stock shall vote with the common stock as a single
class, has liquidation rights of $0.001 per share and is entitled to receive an annal dividend of 6% of the Stated Value (the “Divided
Rate”), which shall be cumulative, payable solely upon redemption, liquidation, or conversion.
As
of June 30, 2024 and December 31, 2023, there are 1,000,000 and 1,000,000 shares of Series G preferred stock issued, respectively.
During
the year ended December 31, 2022, as consideration for the reverse merger, the Company issued 1,000,000 shares of Series G Convertible
Preferred stock.
On
November 18, 2021, pursuant to the Founders Agreement, Michael Lakshin, President, and Edward Aizman, CEO, were issued 500 shares of
Super Preferred Stock at a fair value of $50. These preferred shares, along with the 652,259 Series AA preferred stock, were cancelled
on May 4, 2022, upon completion of the Reverse Merger. See Note 1.
NOTE
13 – COMMITMENTS AND CONTINGENCIES
Contingency
arising from indebtedness owed to Oasis Capital, LLC
A
contingency arises when there is a situation for which the outcome is uncertain, and which should be resolved in the future, Generally
Accepted Accounting Principles require recognition of only those losses that are probable and for which a loss amount can be reasonably
estimated.
The
following details the nature of the contingency with Oasis Capital LLC (“Oasis”). In the normal course of its business, Oasis
files notices to convert (“conversion notices”) a portion of its outstanding ownership of the Company’s indebtedness
into shares of common stock. As a customary procedure for the annual audit for the period ended December 31, 2020, of Cruzani, Cruzani’s
auditors confirmed its outstanding balance of the indebtedness and related accrued interest. During the year ended December 31, 2021,
Oasis submitted conversions which stated that the outstanding indebtedness was far greater than that which was on the Company’s
books. The total amount of the increased indebtedness was approximately $1.2 million. After investigation, the Company determined that
the difference related to liquidated damages that the Company does not believe that it owes.
Since
the Company believes that the loss is not probable and no litigation has been pursued at this time, there has been no recognition of
this liability on the books and records of the Company.
Legal
During
the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates
the merits of the case in accordance with FASB ASC 450-20-50, Contingencies. The Company evaluates its exposure to the matter, possible
legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is
probable and can be reasonably estimated, it establishes the necessary accruals. A contingency arises when there is a situation for which
the outcome is uncertain, and which should be resolved in the future, Generally Accepted Accounting Principles require recognition
of only those losses that are probable and for which a loss amount can be reasonably estimated.
On
February 13, 2017, Baum Glass & Jayne PLLC (“Plaintiff”) obtained a default judgment against the Company in the amount
of $27,084. Plaintiff has not attempted enforced collection. The amount was included in accounts payable as of June 30, 2024.
NOTE
14 – INCOME TAX
There
was no income tax expense reflected in the results of operations for the years ended December 31, 2023 and 2022 because the Company incurred
a net loss for tax purposes.
As
of December 31, 2023 and 2022, the Company had federal and state net operating loss carry forwards of $12,992,877 and $9,243,925, respectively
which may be used to offset future taxable income. Approximately $1,696,000 will begin to expire in 2036 while $5,920,000 will not expire
but will be limited in annual utilization of 80% of current year income.
The
tax effects of temporary differences which give rise to deferred tax assets (liabilities) are summarized as follows:
| |
December
31, 2023 | | |
December
31, 2022 | |
Deferred tax assets / (liabilities) | |
| | |
| |
Net operating loss carry forward | |
$ | 3,361,000 | | |
$ | 2,923,000 | |
Stock-based compensation | |
| 517,618 | | |
| 245,000 | |
Accrued expenses | |
| 192,697 | | |
| 193,000 | |
Net deferred tax assets | |
| 4,017,315 | | |
| 3,361,000 | |
Valuation allowance | |
| (4,017,315 | ) | |
| (3,361,000 | ) |
Net deferred tax assets,
net of valuation allowance | |
$ | - | | |
$ | - | |
In
assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of
the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future
taxable income during the periods in which those temporary differences become deductible. Deferred tax assets consist primarily of the
tax effect of NOL carry-forwards. The Company has provided a full valuation allowance on the deferred tax assets because of the uncertainty
regarding its realizability.
Reconciliation
of the statutory federal income tax to the Company’s effective income tax rate for the years ended December 31, 2023 and 2022:
| |
December
31, 2023 | | |
December
31, 2022 | |
Statutory federal income tax
rate | |
| 21.0 | % | |
| 21.00 | % |
State tax, net of federal benefit | |
| 15.29 | % | |
| 15.29 | % |
Permanent differences | |
| 2.50 | % | |
| 2.50 | % |
Valuation allowance | |
| (38.79 | )% | |
| (38.79 | )% |
Effective rate | |
| - | % | |
| - | % |
Internal
Revenue Code Section 382 limits the ability to utilize net operating losses if a 50% change in ownership occurs over a three-year period.
Such limitation of the net operating losses may have occurred, but we have not analyzed it at this time as the deferred tax asset is
fully reserved.
On
March 27, 2020, the US government signed the CARES Act into law, a $2 trillion relief package to provide support to individuals, businesses,
and government organizations during the COVID-19 pandemic. During 2020, $91,035 in PPP relief was received under the CARES Act and was
forgiven free of taxation in 2021.
The
Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the
statement of operations. As of December 31, 2023 and 2022 the Company had no unrecognized tax benefits. There were no changes in
the Company’s unrecognized tax benefits during the years ended December 31, 2023 and 2022. The Company did not recognize any interest
or penalties during fiscal 2023 or 2022 related to unrecognized tax benefits.
For
the years ended December 31, 2023 and 2022, the net increase in valuation allowance was approximately $710,315 and $1,777,000, respectively.
Tax
years 2018-2021 remain open to examination for federal income tax purposes and by other major taxing jurisdictions to which the Company
is subject.
NOTE
15 – SUBSEQUENT EVENTS
In
accordance with ASC 855-10, the company has analyzed its operations subsequent to June 30, 2024, through the date these financial statements
were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements.
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The
statements contained in the following MD&A and elsewhere throughout this Quarterly Report on Form 10-Q, including any documents incorporated
by reference, that are not historical facts, including statements about our beliefs and expectations, are “forward-looking statements”
within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements preceded
by, followed by or that include the words “may,” “could,” “would,” “should,” “believe,”
“expect,” “anticipate,” “plan,” “estimate,” “target,” “project,”
“intend” and similar words or expressions. In addition, any statements that refer to expectations, projections, or other
characterizations of future events or circumstances are forward-looking statements.
These
forward-looking statements, which reflect our management’s beliefs, objectives, and expectations as of the date hereof, are based
on the best judgement of our management. All forward-looking statements speak only as of the date on which they are made. Such forward-looking
statements are subject to certain risks, uncertainties and assumptions relating to factors that could cause actual results to differ
materially from those anticipated in such statements, including, without limitation, the following: economic, social and political conditions,
global economic downturns resulting from extraordinary events and other securities industry risks; interest rate risks; liquidity risks;
credit risk with clients and counterparties; risk of liability for errors in clearing functions; systemic risk; systems failures, delays
and capacity constraints; network security risks; competition; reliance on external service providers; new laws and regulations affecting
our business; net capital requirements; extensive regulation, regulatory uncertainties and legal matters; failure to maintain relationships
with employees, customers, business partners or governmental entities; the inability to achieve synergies or to implement integration
plans and other consequences associated with risks and uncertainties detailed in our filings with the SEC, including our most recent
filings on Forms 10-K and 10-Q.
We
caution that the foregoing list of factors is not exclusive, and new factors may emerge, or changes to the foregoing factors may occur,
that could impact our business. We undertake no obligation to publicly update or revise these statements, whether as a result of new
information, future events or otherwise, except to the extent required by the federal securities laws.
Certain
information contained in this discussion and elsewhere in this report may include “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995 and is subject to the safe harbor created by that act. The safe harbor
created by the Private Securities Litigation Reform Act will not apply to certain “forward looking statements” because we
issued “penny stock” (as defined in Section 3(a)(51) of the Securities Exchange Act of 1934 and Rule 3(a)(51-1) under the
Exchange Act) during the three year period preceding the date(s) on which those forward looking statements were first made, except to
the extent otherwise specifically provided by rule, regulation or order of the Securities and Exchange Commission. We caution readers
that certain important factors may affect our actual results and could cause such results to differ materially from any forward-looking
statements which may be deemed to have been made in this Report or which are otherwise made by or on our behalf. For this purpose, any
statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without
limiting the generality of the foregoing, words such as “may,” “will,” “expect,” “believe,”
“explore,” “consider,” “anticipate,” “intend,” “could,” “estimate,”
“plan,” or “propose” or the negative variations of those words or comparable terminology are intended to identify
forward-looking statements. Factors that may affect our results include, but are not limited to, the risks and uncertainties associated
with:
|
● |
Our
ability to raise capital necessary to sustain our anticipated operations and implement our business plan, |
|
|
|
|
● |
Our
ability to implement our business plan, |
|
|
|
|
● |
Our
ability to generate sufficient cash to survive, |
|
|
|
|
● |
The
degree and nature of our competition, |
|
|
|
|
● |
The
lack of diversification of our business plan, |
|
|
|
|
● |
The
general volatility of the capital markets and the establishment of a market for our shares, and |
|
|
|
|
● |
Disruption
in the economic and financial conditions primarily from the impact of past terrorist attacks in the United States, threats of future
attacks, police and military activities overseas and other disruptive worldwide political and economic events and environmental weather
conditions. |
We
are also subject to other risks detailed from time to time in our other filings with SEC and elsewhere in this Annual Report. Any one
or more of these uncertainties, risks and other influences could materially affect our results of operations and whether forward-looking
statements made by us ultimately prove to be accurate. Our actual results, performance and achievements could differ materially from
those expressed or implied in these forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking
statements, whether from new information, future events or otherwise.
Recent
Event
On
March 22, 2024, we entered into a Plan and Agreement of Merger (the “Merger Agreement”) with OWNverse, LLC, a Delaware limited
liability company (“OWNverse”), pursuant to which OWNverse would become a wholly-owned subsidiary of our company. Pursuant
to the Merger Agreement, our company would deliver an aggregate of 2,000 shares of to-be-designated Series I Preferred Stock of the Company,
an aggregate of $2,000,000 in principal amount promissory notes that are to be due and payable two years from their issuance dates and
promissory notes with an aggregate of up to $270,000 that are to be due and payable six months from their issuance dates. The consummation
of the Merger Agreement has not been completed, due to our company’s lack of capital. There is no assurance that we will be able
to obtain sufficient capital to do so. However, the owners of OWNverse remain, as of the date of this Quarterly Report, committed to
completing the Merger.
2022
Acquisition – Interview Mastery
Effective
December 16, 2022, pursuant to an Asset Purchase Agreement (the “APA”) with Interview Mastery (“Interview Mastery”),
by and through Michael R. Neece (“Neece”) and Caseridus, Inc. Under the terms of the APA, the Company is to pay the purchase
price through the issuance of 22,000,000 shares of the Company’s common stock in two tranches: (i) 11,000,000 shares of Company
common stock to the stockholders of Interview Mastery that vest immediately for all of the business assets of Interview Mastery, valued
at $200,000 based on the acquisition date share price; and (ii) 11,000,000 shares of Company common stock issued in consideration
of Neece’s employment with the Company which shall vest over a four (4) year period during which 25% of the shares will vest on
the first-year anniversary of Neece’s employment, followed by vesting in increments of 6.25% of the shares per quarter (3-month
period) thereafter until the full amount is vested and all of which shall be contingent upon Neece’s continual employment with
the Company. As of the date of this Annual Report, none of the shares issuable in connection with the APA has been issued, and as such,
has been recorded as a liability in accrued expenses on the consolidated balance sheets. In connection with the APA, the Company is to
create a new board seat and offer such seat to Neece who will be formally invited to join the Company’s Board of Directors. As
of the date of this Annual Report, none of these actions has been taken by the Company.
This
acquisition was accounted for as a business combination in accordance with the acquisition method under the guidance in ASC 805-10 and
805-20. This business combination was accounted for as a related party acquisition, as Neece is the chief product officer of the Company
Accordingly, the total purchase consideration was allocated to net acquired based on their respective historical costs. The assets acquired,
and liabilities assumed, if any, in a business purchase combination be recognized at their historical costs as of the acquisition date.
The
final allocation of the purchase price in connection with the Interview Mastery acquisition was calculated as follows:
Description | |
Fair
Value | | |
Weighted
Average Useful Life (Years) | |
Cash | |
$ | 1,633 | | |
| | |
Prepaid expenses | |
| 997 | | |
| | |
Loss on acquisition
– related party | |
| 197,370 | | |
| | |
No acquisition
costs were incurred. The approximate revenue and net loss for the acquired business as a standalone entity per ASC 805 from January 1,
2021, to December 31, 2021, was $14,692 and $21,862, respectively, and, from January 1, 2022, to December 16, 2022, $13,059 and $15,279,
respectively.
Results
of Operations
The
following discussion and analysis of the results of operations and financial condition for the six months ended June 30, 2024 and 2023,
should be read in conjunction with our consolidated financial statements and the notes to those consolidated financial statements that
are included elsewhere in this Quarterly Report. Our discussion includes forward-looking statements based upon current expectations that
involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events
could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. See “Forward-Looking
Statements.”
Six
Months Ended June 30, 2024, Compared to the Six Months Ended June 30, 2023.
Revenue.
We derived no revenues from operations for the six months ended June 30, 2024, compared to revenues for the six months ended June 30,
2023, of $4,476. Our lack of revenues during current period is due to our lack of operating capital. We are unable to predict if and
when we will obtain the capital needed to begin to generate revenues again.
Cost
of Revenue. Cost of revenues for the six months ended June 30, 2024 and 2023, was $0 and $0, respectively.
Compensation
Expense. Compensation expense for the six months ended June 30, 2024, was $250,000, compared to the six months ended June 30, 2023,
when we reported compensation expense of $222,119. In both periods, compensation expense consisted entirely of compensation paid and
accrued to officers.
Consulting
Expense. Consulting expense for the six months ended June 30, 2024, was $0, compared to the six months ended June 30, 2023, when
consulting expenses was $60,000.
General
and Administrative Expenses. General and administrative expenses for the six months ended June 30, 2024, was $61,606, compared to
$107,421 for the six months ended June 30, 2023. The decrease in the current period is attributable to our lack of operating capital.
Professional
fees. Professional fees for the six months ended June 30, 2024, were $65,000, compared to $163,469 for the six months ended June
30, 2023. The decrease in professional fees is primarily due to our lower level of operations required by our lack of operating capital.
Other
Income (Expense). For the six months ended June 30, 2024, total other expense was $314,480, comprised exclusively of change in fair
value of derivative liability. For the six months ended June 30, 2023, total other expense was $99,553, comprised of change in the value
of derivative liabilities of $32,429 and interest expense of $497,405.
Net
Income (Loss). The Company reported a net loss of $691,086 for the six months ended June 30, 2024, compared to net income of $648,086
for the six months ended June 30, 2023.
Liquidity
and Capital Resources
For
the six months ended June 30, 2024, we used $337,946 of cash in operating activities, compared to the six months ended June 30, 2023,
when we used $88,378 of cash in operating activities.
For
the six months ended June 30, 2024 and 2023, investing activities did not use or provide cash.
For
the six months ended June 30, 2024, financing activities provide $3434,155 of cash, compared to the for the six months ended June 30,
2023, when financing activities used $980 of cash.
The
Company currently owes approximately $500,000 on non-convertible loans payable, all of which are in default, and approximately $450,000
for outstanding convertible notes, net of discounts, all of which are in default.
In
addition, entities negatively impacted by the COVID-19 pandemic were eligible to apply for loans sponsored by the United States Small
Business Administration (SBA) Economic Injury Disaster Loan (“EIDL Loan”) program. On July 15, 2020, the Company received
cash proceeds of $40,400 under this program. In addition, in July 2020, the Company received $6,000 from the SBA as a COVID-19 Economic
Injury Disaster Loan Advance (the “EIDL Advance”). The proceeds can be used to fund payroll, healthcare benefits, rent and
other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include
interest accruing at 3.75% per annum effective July 15, 2020; the payment schedule contains a one-year deferral period on initial principal
and interest payments; the loan term is thirty years; and there is no prepayment penalty or fees. The Company pledged all assets of the
Company as collateral for the loan. As of December 31, 2021, the amounts outstanding totaled $40,400, and was classified as part of notes
payable on the consolidated balance sheet. Additionally, the Company entered into a security agreement with the SBA in which this promissory
note is collateralized by all tangible and intangible assets of the Company. In addition, the Company’s CEO, Edward Aizman, provided
his personal guaranty of the EIDL Loan and pledged certain of his personal assets in conjunction with his guaranty. On January 6, 2021,
the SBA announced a one-year extension of the deferral period for loans that commenced in 2020 delaying payments of principal and interest
to July 2022. Pursuant to an SBA Procedural Notice in December 2020, the EIDL Advance was forgiven. The Company has recognized the entire
EIDL Advance amount of $6,000 as grant income, which is included in other income (expense) in the consolidated statement of operations
for the year ended December 31, 2021.
In
February 2022, the Company agreed to the first and second modifications of the EIDL Loan. The EIDL was modified to include additional
borrowings of $269,200, which were received in full in February 2022. Periodic monthly payments have increased to $1,556 in the first
modification and reduced to $1,506 in the second modification. Additionally, the Company entered into an amended security agreement with
the SBA in which this promissory note, and the modifications, is collateralized by all tangible and intangible assets of the Company.
The balance of the EIDL loan balance at December 31, 2023 is $309,500, respectively. The Company is in default under the EIDL Loan and
the EIDL Loan has been referred by the SBA to the U.S. Treasury Offset Program. The Company is currently in the process of addressing
the charged-off status of the EIDL Loan with the SBA and simultaneously submitting an application to the SBA’s Hardship Accommodation
Program (HAP), whereby the Company hopes to receive some relief while arranging for, and keeping current, reduced payments thereon. There
is no assurance that the Company will be able to secure any such relief.
Going
Concern
The
accompanying unaudited interim consolidated condensed financial statements have been prepared in conformity with generally accepted accounting
principles which contemplate continuation of the Company on a going-concern basis. The going concern basis assumes that assets are realized,
and liabilities are extinguished in the ordinary course of business at amounts disclosed in the consolidated financial statements. The
Company has incurred recurring losses from operations and has an accumulated deficit of $(13,683,963). The Company’s ability to
continue as a going concern depends upon its ability to obtain adequate funding to support its operations through continuing investments
of debt and/or equity by qualified investors/creditors, internally generated working capital and monetization of intellectual property
assets. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial
statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management
is currently pursuing a business strategy which includes raising the necessary funds to finance the Company’s development and marketing
efforts.
Critical
Accounting Estimates and Policies
The
preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent
assets and liabilities of the date of the financial statements and the reported amounts of revenues and expenses during the reporting
period. Note 1 to the Financial Statements describes the significant accounting policies and methods used in the preparation of the Financial
Statements. Estimates are used for, but not limited to, contingencies and taxes. Actual results could differ materially from those estimates.
The following critical accounting policies are impacted significantly by judgments, assumptions, and estimates used in the preparation
of the Financial Statements.
We
are subject to various loss contingencies arising in the ordinary course of business. We consider the likelihood of loss or impairment
of an asset or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies.
An estimated loss contingency is accrued when management concludes that it is probable that an asset has been impaired or a liability
has been incurred and the amount of the loss can be reasonably estimated. We regularly evaluate current information available to us to
determine whether such accruals should be adjusted.
We
recognize deferred tax assets (future tax benefits) and liabilities for the expected future tax consequences of temporary differences
between the book carrying amounts and the tax basis of assets and liabilities. The deferred tax assets and liabilities represent the
expected future tax return consequences of those differences, which are expected to be either deductible or taxable when the assets and
liabilities are recovered or settled. Future tax benefits have been fully offset by a 100% valuation allowance as management is unable
to determine that it is more likely than not that this deferred tax asset will be realized.
Recent
Accounting Pronouncements
The
Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on
the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements
that have been issued that might have a material impact on its financial position or results of operations.
Off
Balance Sheet Arrangements
We
have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our
financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or
capital resources and would be considered material to investors.
Item
3. Quantitative and Qualitative Disclosures about Market Risk.
Not
applicable to smaller reporting companies.
Item
4. Controls and Procedures.
Evaluation
of Disclosure Controls and Procedures
We
maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be
disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in
the rules and forms of the Securities and Exchange Commission (the “SEC”), and that such information is accumulated and communicated
to our management to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer evaluated
the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation,
they concluded that our disclosure controls and procedures were not effective for the quarterly period ended June 30, 2024.
The
following aspects of the Company were noted as potential material weaknesses:
|
1. |
We do not have written
documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting
is a requirement of Section 404 of the Sarbanes-Oxley Act which is applicable to us for the period ended June 30, 2024. Management
evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our
disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness. |
|
2. |
We do not have sufficient
resources in our accounting function, which restricts the Company’s ability to gather, analyze and properly review information
related to financial reporting in a timely manner. As a result, as of the date of filing, we have not completed our ASC 606 implementation
process and, thus, cannot disclose the quantitative impact of adoption on our financial statements. In addition, due to our size
and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the
extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate
individuals. Management evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls
and procedures and has concluded that the control deficiency that resulted represented a material weakness. |
|
3. |
We have inadequate controls
to ensure that information necessary to properly record transactions is adequately communicated on a timely basis from non-financial
personnel to those responsible for financial reporting. Management evaluated the impact of the lack of timely communication between
non–financial personnel and financial personnel on our assessment of our reporting controls and procedures and has concluded
that the control deficiency represented a material weakness. |
|
4. |
Certain control procedures
were unable to be verified due to performance not being sufficiently documented. As an example, some procedures requiring review
of certain reports could not be verified due to there being no written documentation of such review. Management evaluated the impact
of its failure to maintain proper documentation of the review process on its assessment of its reporting controls and procedures
and has concluded deficiencies represented a material weakness. |
In
designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well
designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a
control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to
their costs.
Changes
in Internal Controls
Based
on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that no change occurred in the Company’s
internal controls over financial reporting during the quarter ended June 30, 2024, that has materially affected, or is reasonably likely
to materially affect, the Company’s internal controls over financial reporting.
PART
II – OTHER INFORMATION
Item.
1. Legal Proceedings.
From
time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation
is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.
As
of the date of this filing, there are no material pending legal or governmental proceedings relating to our Company or properties to
which we are a party, and, to our knowledge, there are no material proceedings to which any of our directors, executive officers, or
affiliates are a party adverse to us or which have a material interest adverse to us.
Item
1A. Risk Factors.
We
are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide
the information under this Item.
Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.
We
issued no securities during the three months ended June 30, 2024, not previously reported.
Item
3. Defaults Upon Senior Securities.
None
Item
4. Mine Safety Disclosures.
Not
applicable.
Item
5. Other Information.
None.
Item
6. Exhibits
SIGNATURES
In
accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
BOWMO, INC. |
|
|
|
Date: November 13, 2024 |
By: |
/s/
Michael Lakshin |
|
Name: |
Michael Lakshin |
|
Title: |
President and Chairman
of the Board |
|
|
(Principal Executive Officer) |
|
|
(Principal Financial and
Accounting Officer) |
29
NONE
false
--12-31
Q2
0001381871
0001381871
2024-01-01
2024-06-30
0001381871
2024-11-13
0001381871
2024-06-30
0001381871
2023-12-31
0001381871
bomo:MichaelLaskshinMember
2024-06-30
0001381871
bomo:MichaelLaskshinMember
2023-12-31
0001381871
bomo:EddieAMember
2024-06-30
0001381871
bomo:EddieAMember
2023-12-31
0001381871
us-gaap:RelatedPartyMember
2024-06-30
0001381871
us-gaap:RelatedPartyMember
2023-12-31
0001381871
us-gaap:SeriesAPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesAPreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesBPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesBPreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesCPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesCPreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesDPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesDPreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesEPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesEPreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesFPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesFPreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesGPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesGPreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesHPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesHPreferredStockMember
2023-12-31
0001381871
bomo:SeriesAAPreferredStockMember
2024-06-30
0001381871
bomo:SeriesAAPreferredStockMember
2023-12-31
0001381871
bomo:SeriesSuperPreferredStockMember
2024-06-30
0001381871
bomo:SeriesSuperPreferredStockMember
2023-12-31
0001381871
us-gaap:CommonStockMember
2024-06-30
0001381871
us-gaap:CommonStockMember
2023-12-31
0001381871
2024-04-01
2024-06-30
0001381871
2023-04-01
2023-06-30
0001381871
2023-01-01
2023-06-30
0001381871
bomo:PreferredStockAAMember
us-gaap:PreferredStockMember
2022-12-31
0001381871
bomo:SuperPreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001381871
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001381871
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001381871
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001381871
us-gaap:SeriesDPreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001381871
us-gaap:SeriesEPreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001381871
us-gaap:SeriesGPreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001381871
us-gaap:SeriesHPreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001381871
us-gaap:CommonStockMember
2022-12-31
0001381871
bomo:CommonStockToBeIssuedMember
2022-12-31
0001381871
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001381871
us-gaap:TreasuryStockCommonMember
2022-12-31
0001381871
us-gaap:RetainedEarningsMember
2022-12-31
0001381871
2022-12-31
0001381871
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-06-30
0001381871
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001381871
bomo:PreferredStockAAMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001381871
bomo:SuperPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001381871
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001381871
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001381871
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001381871
us-gaap:SeriesDPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001381871
us-gaap:SeriesEPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001381871
us-gaap:SeriesGPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001381871
us-gaap:SeriesHPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001381871
bomo:CommonStockToBeIssuedMember
2023-01-01
2023-06-30
0001381871
us-gaap:TreasuryStockCommonMember
2023-01-01
2023-06-30
0001381871
us-gaap:RetainedEarningsMember
2023-01-01
2023-06-30
0001381871
bomo:PreferredStockAAMember
us-gaap:PreferredStockMember
2023-06-30
0001381871
bomo:SuperPreferredStockMember
us-gaap:PreferredStockMember
2023-06-30
0001381871
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2023-06-30
0001381871
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2023-06-30
0001381871
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2023-06-30
0001381871
us-gaap:SeriesDPreferredStockMember
us-gaap:PreferredStockMember
2023-06-30
0001381871
us-gaap:SeriesEPreferredStockMember
us-gaap:PreferredStockMember
2023-06-30
0001381871
us-gaap:SeriesGPreferredStockMember
us-gaap:PreferredStockMember
2023-06-30
0001381871
us-gaap:SeriesHPreferredStockMember
us-gaap:PreferredStockMember
2023-06-30
0001381871
us-gaap:CommonStockMember
2023-06-30
0001381871
bomo:CommonStockToBeIssuedMember
2023-06-30
0001381871
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001381871
us-gaap:TreasuryStockCommonMember
2023-06-30
0001381871
us-gaap:RetainedEarningsMember
2023-06-30
0001381871
2023-06-30
0001381871
bomo:PreferredStockAAMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
bomo:SuperPreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesDPreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesEPreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesGPreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
us-gaap:SeriesHPreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
us-gaap:CommonStockMember
2023-12-31
0001381871
bomo:CommonStockToBeIssuedMember
2023-12-31
0001381871
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001381871
us-gaap:TreasuryStockCommonMember
2023-12-31
0001381871
us-gaap:RetainedEarningsMember
2023-12-31
0001381871
us-gaap:SeriesHPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001381871
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-06-30
0001381871
bomo:PreferredStockAAMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SuperPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
us-gaap:SeriesDPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
us-gaap:SeriesEPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
us-gaap:SeriesGPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:CommonStockToBeIssuedMember
2024-01-01
2024-06-30
0001381871
us-gaap:TreasuryStockCommonMember
2024-01-01
2024-06-30
0001381871
us-gaap:RetainedEarningsMember
2024-01-01
2024-06-30
0001381871
bomo:PreferredStockAAMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
bomo:SuperPreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesDPreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesEPreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesGPreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesHPreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
us-gaap:CommonStockMember
2024-06-30
0001381871
bomo:CommonStockToBeIssuedMember
2024-06-30
0001381871
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0001381871
us-gaap:TreasuryStockCommonMember
2024-06-30
0001381871
us-gaap:RetainedEarningsMember
2024-06-30
0001381871
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:SeriesGPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2024-06-30
0001381871
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:SeriesAPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:SeriesBPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:SeriesCPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:SeriesDPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:SeriesEPreferredStockMember
2024-06-30
0001381871
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:SeriesFPreferredStockMember
2024-06-30
0001381871
2023-01-01
2023-12-31
0001381871
2022-01-01
2022-12-31
0001381871
bomo:DirectPlacementMember
srt:MinimumMember
2024-01-01
2024-06-30
0001381871
bomo:DirectPlacementMember
srt:MaximumMember
2024-01-01
2024-06-30
0001381871
bomo:DirectPlacementMember
2024-01-01
2024-06-30
0001381871
bomo:DirectPlacementMember
2023-01-01
2023-06-30
0001381871
bomo:RecruitingAsAServiceMember
2024-01-01
2024-06-30
0001381871
bomo:RecruitingAsAServiceMember
2023-01-01
2023-06-30
0001381871
us-gaap:CommonStockMember
2022-12-16
2022-12-16
0001381871
bomo:AssetPurchaseAgreementMember
bomo:InterviewMasteryAcquisitionMember
2022-12-16
0001381871
bomo:InterviewMasteryAcquisitionMember
us-gaap:CommonStockMember
2022-12-16
2022-12-16
0001381871
bomo:AssetPurchaseAgreementMember
bomo:MichaelRNeeceMember
2022-12-16
2022-12-16
0001381871
bomo:AssetPurchaseAgreementMember
2022-12-16
2022-12-16
0001381871
bomo:AssetPurchaseAgreementMember
bomo:MichaelRNeeceMember
2022-12-16
0001381871
us-gaap:GeneralAndAdministrativeExpenseMember
2024-01-01
2024-06-30
0001381871
bomo:InterviewMasteryAcquisitionMember
2024-01-01
2024-06-30
0001381871
2021-01-01
2021-12-31
0001381871
bomo:LoanOneMember
bomo:CruzaniMember
2013-05-30
2013-05-30
0001381871
bomo:LoanOneMember
bomo:CruzaniMember
2013-08-12
2013-08-12
0001381871
bomo:LoanOneMember
2013-08-12
2013-08-12
0001381871
bomo:LoanOneMember
2024-06-30
0001381871
bomo:Loan2Member
2014-02-27
2014-02-27
0001381871
bomo:Loan2Member
2015-03-19
2015-03-19
0001381871
bomo:Loan2Member
2015-12-31
2015-12-31
0001381871
bomo:Loan2Member
2024-06-30
0001381871
bomo:Loan3Member
2014-09-18
2014-09-18
0001381871
bomo:Loan3Member
2015-05-29
2015-05-29
0001381871
bomo:Loan3Member
2015-07-03
2015-07-03
0001381871
bomo:Loan3Member
2015-12-02
2015-12-02
0001381871
bomo:Loan3Member
2016-01-04
2016-01-04
0001381871
bomo:Loan3Member
2024-06-30
0001381871
bomo:Loan4Member
2014-12-04
2014-12-04
0001381871
bomo:Loan4Member
2015-01-29
2015-01-29
0001381871
bomo:Loan4Member
2015-08-12
2015-08-12
0001381871
bomo:Loan4Member
2015-08-21
2015-08-21
0001381871
bomo:Loan4Member
2015-09-01
2015-09-01
0001381871
bomo:Loan4Member
2015-09-15
2015-09-15
0001381871
bomo:Loan4Member
2015-11-13
2015-11-13
0001381871
bomo:Loan4Member
2015-12-23
2015-12-23
0001381871
bomo:Loan4Member
2024-06-30
0001381871
bomo:Loan5Member
bomo:UnitedStatesSmallBusinessAdministrationMember
2020-07-15
2020-07-15
0001381871
bomo:EDILAdvanceMember
bomo:UnitedStatesSmallBusinessAdministrationMember
2020-07-01
2020-07-31
0001381871
bomo:Loan5Member
2020-07-15
0001381871
bomo:Loan5Member
2024-01-01
2024-06-30
0001381871
bomo:Loan5Member
2021-12-31
0001381871
bomo:Loan5Member
2021-01-01
2021-12-31
0001381871
bomo:Loan5Member
2022-02-01
2022-02-28
0001381871
srt:MaximumMember
bomo:Loan5Member
2022-02-01
2022-02-28
0001381871
srt:MinimumMember
bomo:Loan5Member
2022-02-01
2022-02-28
0001381871
bomo:EIDLLoanMember
2024-06-30
0001381871
bomo:EIDLLoanMember
2023-12-31
0001381871
bomo:LoanOneMember
2024-01-01
2024-06-30
0001381871
bomo:LoanOneMember
2024-06-30
0001381871
bomo:LoanOneMember
2023-12-31
0001381871
bomo:Loan2Member
2024-01-01
2024-06-30
0001381871
bomo:Loan2Member
2024-06-30
0001381871
bomo:Loan2Member
2023-12-31
0001381871
bomo:Loan3Member
2024-01-01
2024-06-30
0001381871
bomo:Loan3Member
2024-06-30
0001381871
bomo:Loan3Member
2023-12-31
0001381871
bomo:Loan4Member
2024-01-01
2024-06-30
0001381871
bomo:Loan4Member
2024-06-30
0001381871
bomo:Loan4Member
2023-12-31
0001381871
bomo:Loan5Member
2024-06-30
0001381871
bomo:Loan5Member
2023-12-31
0001381871
bomo:CruzaniMember
2024-06-30
0001381871
bomo:FrondeurMember
2022-12-01
0001381871
bomo:FrondeurMember
2022-12-01
0001381871
srt:MinimumMember
bomo:FrondeurMember
2022-06-01
2022-12-01
0001381871
srt:MaximumMember
bomo:FrondeurMember
2022-06-01
2022-12-01
0001381871
bomo:ConvertibleNotesMember
2024-06-30
0001381871
bomo:ConvertibleNotesMember
2023-12-31
0001381871
bomo:FrondeurPartnersLLCMember
2022-05-01
0001381871
srt:MinimumMember
bomo:TwoConvertibleNotesMember
2022-05-01
2022-05-01
0001381871
bomo:FrondeurPartnersLLCMember
2024-06-30
0001381871
2024-01-01
0001381871
2024-02-01
0001381871
2024-03-01
0001381871
bomo:FrondeurPartnersLLCMember
2023-12-31
0001381871
us-gaap:WarrantMember
2024-01-01
2024-06-30
0001381871
bomo:KingWharfOpportunitiesFundMember
2022-10-19
0001381871
bomo:KingsWharfMember
2022-10-19
2022-10-19
0001381871
bomo:KingWharfOpportunitiesFundMember
2022-10-19
2022-10-19
0001381871
bomo:KingsWharfMember
us-gaap:SeriesGPreferredStockMember
2022-10-19
0001381871
bomo:KingWharfOpportunitiesFundMember
us-gaap:SeriesGPreferredStockMember
2022-10-19
0001381871
bomo:KingsWharfMember
2023-12-31
0001381871
bomo:KingsWharfMember
2024-06-30
0001381871
bomo:DiagonalLendingMember
2023-11-10
0001381871
bomo:DiagonalLendingMember
2023-11-10
0001381871
bomo:DiagonalLendingMember
2023-11-10
2023-11-10
0001381871
bomo:DiagonalLendingMember
bomo:ConvertibleNotesMember
2023-12-31
0001381871
bomo:DiagonalLendingMember
bomo:ConvertibleNotesMember
2024-06-30
0001381871
bomo:DiagonalLendingMember
2023-12-12
0001381871
bomo:DiagonalLendingMember
2023-12-12
2023-12-12
0001381871
bomo:DiagonalLendingMember
2024-06-30
0001381871
bomo:DiagonalLendingMember
2023-12-31
0001381871
bomo:DiagonalLendingMember
2024-01-01
2024-06-30
0001381871
bomo:DiagonalLendingOneMember
2024-06-30
0001381871
bomo:DiagonalLendingOneMember
2023-12-31
0001381871
bomo:TwoConvertibleNotesMember
bomo:TrilliumPartnersLpMember
2021-07-06
0001381871
bomo:TrilliumPartnersLpMember
2024-06-30
0001381871
bomo:TrilliumPartnersLpMember
2023-12-31
0001381871
srt:MinimumMember
bomo:SeveralConvertibleNotesMember
bomo:TrilliumPartnersLpMember
2022-12-06
0001381871
srt:MaximumMember
bomo:SeveralConvertibleNotesMember
bomo:TrilliumPartnersLpMember
2022-12-06
0001381871
bomo:SeveralConvertibleNotesMember
bomo:TrilliumPartnersLpMember
2022-12-06
0001381871
srt:MinimumMember
bomo:SeveralConvertibleNotesMember
bomo:TrilliumPartnersLpMember
2022-06-01
2022-12-06
0001381871
srt:MaximumMember
bomo:SeveralConvertibleNotesMember
bomo:TrilliumPartnersLpMember
2022-06-01
2022-12-06
0001381871
bomo:TrilliumPartnersLPOneMember
2024-06-30
0001381871
bomo:TrilliumPartnersLPOneMember
2023-12-31
0001381871
bomo:TrilliumPartnersLpMember
2022-10-19
2022-10-19
0001381871
bomo:TrilliumPartnersLpMember
2022-10-19
0001381871
2022-10-19
0001381871
bomo:TrilliumPartnersLpMember
2022-10-19
2022-10-19
0001381871
bomo:MrAizmanAndMrLakshinMember
us-gaap:SeriesGPreferredStockMember
2022-10-19
0001381871
bomo:ConvertibleNotesMember
us-gaap:SeriesGPreferredStockMember
2022-10-19
0001381871
bomo:TrilliumPartnersLPTwoMember
2023-12-31
0001381871
bomo:TrilliumPartnersLPTwoMember
2024-06-30
0001381871
srt:MinimumMember
bomo:TrilliumPartnersLpMember
2024-01-01
2024-06-30
0001381871
srt:MaximumMember
bomo:TrilliumPartnersLpMember
2024-01-01
2024-06-30
0001381871
bomo:TrilliumPartnersLpMember
2024-06-30
0001381871
bomo:TrilliumPartnersLpMember
2024-01-01
2024-06-30
0001381871
bomo:MatterhornPartnersLLCMember
2023-08-15
2023-08-15
0001381871
bomo:MatterhornPartnersLLCMember
2023-08-15
0001381871
bomo:TrilliumPartnersLpMember
2023-08-15
0001381871
bomo:MatterhornMember
2023-08-15
2023-08-15
0001381871
bomo:MatterhornPartnersLLCMember
2024-06-30
0001381871
bomo:MatterhornPartnersLLCMember
2023-12-31
0001381871
bomo:ConvertiblePromissoryNoteMember
bomo:TravelDataSolutionsMember
2017-11-18
0001381871
bomo:TravelDataSolutionsMember
2017-11-18
2017-11-18
0001381871
bomo:TravelDataSolutionsMember
2018-01-01
2018-01-31
0001381871
bomo:TravelDataSolutionsMember
2018-02-01
2018-02-28
0001381871
bomo:TravelDataSolutionsMember
2024-06-30
0001381871
bomo:TravelDataSolutionsMember
2023-12-31
0001381871
2021-10-01
2021-10-01
0001381871
2021-10-01
0001381871
bomo:TwoConvertibleNotesMember
2021-10-01
2021-10-01
0001381871
2021-11-17
2021-11-17
0001381871
2021-11-17
0001381871
bomo:TwoConvertibleNotesMember
2021-11-17
2021-11-17
0001381871
bomo:ThirdPartyMember
2020-07-07
2020-07-07
0001381871
bomo:ThirdPartyMember
2020-07-07
0001381871
bomo:ThirdPartyMember
2024-06-30
0001381871
bomo:ThirdPartyMember
2023-12-31
0001381871
bomo:FrondeurMember
2024-06-30
0001381871
bomo:FrondeurMember
2023-12-31
0001381871
bomo:PremiumOnStockSettledDebtMember
bomo:FrondeurMember
2023-12-31
0001381871
bomo:PremiumOnStockSettledDebtMember
bomo:KingsWharfMember
2023-12-31
0001381871
bomo:OneEightZeroZeroDiagonalLendingMember
2024-06-30
0001381871
bomo:OneEightZeroZeroDiagonalLendingMember
2023-12-31
0001381871
bomo:PremiumOnStockSettledDebtMember
bomo:OneEightZeroZeroDiagonalLendingMember
2023-12-31
0001381871
bomo:TrilliumMember
2024-06-30
0001381871
bomo:TrilliumMember
2023-12-31
0001381871
bomo:PremiumOnStockSettledDebtMember
bomo:TrilliumMember
2023-12-31
0001381871
bomo:MatterhornMember
2024-06-30
0001381871
bomo:MatterhornMember
2023-12-31
0001381871
bomo:PremiumOnStockSettledDebtMember
bomo:MatterhornMember
2023-12-31
0001381871
bomo:PremiumOnStockSettledDebtMember
bomo:TravelDataSolutionsMember
2023-12-31
0001381871
bomo:PremiumOnStockSettledDebtMember
bomo:ThirdPartyMember
2023-12-31
0001381871
bomo:PremiumOnStockSettledDebtMember
2023-12-31
0001381871
2021-12-31
0001381871
srt:MinimumMember
us-gaap:MeasurementInputSharePriceMember
2024-06-30
0001381871
srt:MaximumMember
us-gaap:MeasurementInputSharePriceMember
2024-06-30
0001381871
srt:MinimumMember
us-gaap:MeasurementInputSharePriceMember
2023-12-31
0001381871
srt:MaximumMember
us-gaap:MeasurementInputSharePriceMember
2023-12-31
0001381871
srt:MinimumMember
us-gaap:MeasurementInputExercisePriceMember
2024-06-30
0001381871
srt:MaximumMember
us-gaap:MeasurementInputExercisePriceMember
2024-06-30
0001381871
srt:MinimumMember
us-gaap:MeasurementInputExercisePriceMember
2023-12-31
0001381871
srt:MaximumMember
us-gaap:MeasurementInputExercisePriceMember
2023-12-31
0001381871
srt:MinimumMember
us-gaap:MeasurementInputExpectedTermMember
2024-06-30
0001381871
srt:MaximumMember
us-gaap:MeasurementInputExpectedTermMember
2024-06-30
0001381871
srt:MinimumMember
us-gaap:MeasurementInputExpectedTermMember
2023-12-31
0001381871
srt:MaximumMember
us-gaap:MeasurementInputExpectedTermMember
2023-12-31
0001381871
srt:MinimumMember
us-gaap:MeasurementInputOptionVolatilityMember
2024-06-30
0001381871
srt:MaximumMember
us-gaap:MeasurementInputOptionVolatilityMember
2024-06-30
0001381871
srt:MinimumMember
us-gaap:MeasurementInputOptionVolatilityMember
2023-12-31
0001381871
srt:MaximumMember
us-gaap:MeasurementInputOptionVolatilityMember
2023-12-31
0001381871
srt:MinimumMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-06-30
0001381871
srt:MaximumMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-06-30
0001381871
srt:MinimumMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2023-12-31
0001381871
srt:MaximumMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2023-12-31
0001381871
bomo:MichaelNeeceMember
2022-12-31
0001381871
bomo:MichaelNeeceMember
2023-12-31
0001381871
bomo:MichaelNeeceMember
2024-06-30
0001381871
bomo:EddieAizmanMember
2024-01-01
2024-06-30
0001381871
bomo:MichaelLakshinMember
2024-01-01
2024-06-30
0001381871
bomo:EddieAizmanMember
2022-01-01
2022-12-31
0001381871
bomo:MichaelLakshinMember
2022-01-01
2022-12-31
0001381871
bomo:EddieAizmanMember
2024-06-30
0001381871
bomo:MichaelLakshinMember
2023-12-31
0001381871
bomo:MichaelLakshinMember
2024-06-30
0001381871
2019-07-08
2019-07-08
0001381871
bomo:InterviewMasteryAcquisitionMember
2022-12-16
2022-12-16
0001381871
bomo:InterviewMasteryAcquisitionMember
bomo:MichaelRNeeceMember
2022-12-16
2022-12-16
0001381871
bomo:MichaelRNeeceMember
2022-12-16
2022-12-16
0001381871
srt:ChiefExecutiveOfficerMember
bomo:MichaelRNeeceMember
bomo:ShareBasedCompensationAwardTrancheOneToFourMember
2022-12-16
0001381871
bomo:MichaelRNeeceMember
bomo:ShareBasedCompensationAwardTranchePerQuarterMember
2022-12-16
0001381871
bomo:MichaelRNeeceMember
2022-12-16
0001381871
bomo:MichaelRNeeceMember
2023-01-01
2023-12-31
0001381871
bomo:PreReverseSplitMember
2024-01-01
2024-06-30
0001381871
bomo:PostReverseSplitMember
2024-01-01
2024-06-30
0001381871
srt:MaximumMember
2024-06-30
0001381871
srt:MinimumMember
2024-06-30
0001381871
srt:MinimumMember
us-gaap:WarrantMember
2024-06-30
0001381871
srt:MaximumMember
us-gaap:WarrantMember
2024-06-30
0001381871
srt:MinimumMember
us-gaap:WarrantMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-06-30
0001381871
srt:MaximumMember
us-gaap:WarrantMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-06-30
0001381871
srt:MinimumMember
us-gaap:WarrantMember
us-gaap:MeasurementInputPriceVolatilityMember
2024-06-30
0001381871
srt:MaximumMember
us-gaap:WarrantMember
us-gaap:MeasurementInputPriceVolatilityMember
2024-06-30
0001381871
srt:MinimumMember
us-gaap:WarrantMember
us-gaap:MeasurementInputExpectedTermMember
2024-06-30
0001381871
srt:MaximumMember
us-gaap:WarrantMember
us-gaap:MeasurementInputExpectedTermMember
2024-06-30
0001381871
us-gaap:WarrantMember
2023-12-30
0001381871
us-gaap:WarrantMember
2023-12-31
2023-12-31
0001381871
us-gaap:WarrantMember
2024-01-01
2024-06-30
0001381871
us-gaap:WarrantMember
2024-06-30
0001381871
2007-12-04
2008-12-03
0001381871
bomo:SeriesAAAndSuperConvertiblePreferredStockMember
2024-06-30
0001381871
bomo:SeriesAAAndSuperConvertiblePreferredStockMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesAAAndSuperConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesAAAndSuperConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
bomo:SeriesAAAndSuperConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
bomo:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
bomo:SeriesAConvertiblePreferredStockMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesAConvertiblePreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesAConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
bomo:SeriesBConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
bomo:SeriesBConvertiblePreferredStockMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesBConvertiblePreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesBConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesBConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
bomo:SeriesCConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
bomo:SeriesCConvertiblePreferredStockMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesCConvertiblePreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesCConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesCConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
bomo:SeriesDConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
bomo:SeriesDConvertiblePreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesDConvertiblePreferredStockMember
2024-06-30
0001381871
bomo:SeriesDConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
bomo:SeriesEConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
bomo:SeriesEConvertiblePreferredStockMember
2024-06-30
0001381871
bomo:SeriesEConvertiblePreferredStockMember
2024-01-01
2024-06-30
0001381871
srt:MinimumMember
bomo:SeriesEConvertiblePreferredStockMember
2024-01-01
2024-06-30
0001381871
srt:MaximumMember
bomo:SeriesEConvertiblePreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesFConvertiblePreferredStockMember
2024-06-30
0001381871
bomo:SeriesFConvertiblePreferredStockMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesFConvertiblePreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesFConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesFConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
bomo:SeriesFConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
bomo:SeriesGConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2024-06-30
0001381871
bomo:SeriesGConvertiblePreferredStockMember
2024-01-01
2024-06-30
0001381871
bomo:SeriesGConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001381871
bomo:SeriesGConvertiblePreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001381871
us-gaap:PreferredStockMember
2021-11-18
0001381871
bomo:SeriesAAPreferredStockMember
us-gaap:PreferredStockMember
2021-11-18
0001381871
2017-02-13
2017-02-13
0001381871
bomo:TaxYearExpirable2036Member
2024-06-30
0001381871
bomo:NonExpirableMember
2024-06-30
0001381871
2020-03-27
2020-03-27
0001381871
bomo:CARESActMember
2020-01-01
2020-12-31
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
The certification set forth below is being submitted
in connection with this Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Report”) for the purpose of
complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350
of Chapter 63 of Title 18 of the United States Code.